— Know what they know.
Not Investment Advice

BCLI OTC

Brainstorm Cell Therapeutics Inc.
1W: -4.1% 1M: -26.8% 3M: -28.4% YTD: +52.5% 1Y: +31.0% 3Y: -84.1% 5Y: -98.2%
$0.93
-0.07 (-6.98%)
 
Weekly Expected Move ±11.5%
$1 $1 $1 $1 $1
OTC · Healthcare · Biotechnology · Tech Score Neutral · Power 52 · $10.3M mcap · 8M float · 0.313% daily turnover · Short 32% of daily vol
#802 of 1064
Biotechnology
Healthcare · Micro Cap · 779 peers
Market Share
0.0%
Top 4 Concentration: 22.6%

Technical Signal Map

102 Bullish
49 Neutral
629 Bearish
BCLI $10M
Brainstorm Cell Therapeutics Inc.
NEUTRAL 0
ABSI $1.9B
Absci Corporation
BULLISH +100
PMVP $100M
PMV Pharmaceuticals, Inc.
BULLISH +100
ICU $10M
SeaStar Medical Holding Corporation
BULLISH +100
FTRE $1.9B
Fortrea Holdings Inc.
BULLISH +91
NVAX $1.7B
Novavax, Inc.
BULLISH +91
SEER $120M
Seer, Inc.
BULLISH +91
NAUT $250M
Nautilus Biotechnolgy, Inc.
BULLISH +87
TLSA $70M
Tiziana Life Sciences Ltd
BULLISH +84
AGEN $350M
Agenus Inc.
BULLISH +82
DNA $810M
Ginkgo Bioworks Holdings, Inc.
BULLISH +78
YDES $570M
YD Bio Limited Ordinary Shares
BULLISH +78
DMAC $440M
DiaMedica Therapeutics Inc.
BULLISH +78
SRZN $220M
Surrozen, Inc.
BULLISH +78
MREO $60M
Mereo BioPharma Group plc
BULLISH +78
CVM $20M
CEL-SCI Corporation
BULLISH +78
SXTP —
60 Degrees Pharmaceuticals, Inc.
BULLISH +78
SPHRF $240M
Starpharma Holdings Limited
BULLISH +75
INKT $60M
MiNK Therapeutics, Inc.
BULLISH +75
CRVO $30M
CervoMed Inc.
BULLISH +75
YDESW —
YD Bio Limited Warrants
BULLISH +75
BCTXZ —
BriaCell Therapeutics Corp. Warrant
BULLISH +73
MBXBF $30M
Microbix Biosystems Inc.
BULLISH +68
ZIVO $20M
ZIVO Bioscience, Inc.
BULLISH +68
SLGL $240M
Sol-Gel Technologies Ltd.
BULLISH +66
BYSI $30M
BeyondSpring Inc.
BULLISH +66
PULM $10M
Pulmatrix, Inc.
BULLISH +66
DRTSW $1.6B
Alpha Tau Medical Ltd.
BULLISH +65
TTRX $400M
Turn Therapeutics Inc.
BULLISH +65
OBIO $360M
Orchestra BioMed Holdings, Inc.
BULLISH +65
NTRB $90M
Nutriband Inc.
BULLISH +65
ATGGF $220M
Actinogen Medical Limited
BULLISH +62
DMTRF $350M
3-D Matrix, Ltd.
BULLISH +59
LITS $50M
Lite Strategy, Inc.
BULLISH +59
GRDX $30M
GridAI Technologies Corp.
BULLISH +59
LKFT $1.9B
Lakefront Biotherapeutics N.V.
BULLISH +58
XERS $1.6B
Xeris Biopharma Holdings, Inc.
BULLISH +58
RIGL $870M
Rigel Pharmaceuticals, Inc.
BULLISH +58
GYRE $790M
Gyre Therapeutics, Inc.
BULLISH +58
ENGN $130M
enGene Holdings Inc.
BULLISH +58
NRXS $90M
NeurAxis, Inc.
BULLISH +58
RLYB $90M
Rallybio Corporation
BULLISH +58
ABPO —
Abpro Holdings, Inc.
BULLISH +58
NMAD $50M
NOMAD Power Solutions, Inc.
BULLISH +55
PPTDF $940M
PeptiDream Inc.
BULLISH +53
CELU $50M
Celularity Inc.
BULLISH +53
ANTX $210M
AN2 Therapeutics, Inc.
BULLISH +52
CASBF $1.6B
CanSino Biologics Inc.
BULLISH +51
FLNA $40M
Filana Therapeutics, Inc.
BULLISH +50
HRGN $40M
Harvard Apparatus Regenerative Technology Inc.
BULLISH +50
INAB $10M
IN8bio, Inc.
BULLISH +50
VCNX —
Vaccinex, Inc.
BULLISH +50
HEPA —
Hepion Pharmaceuticals, Inc.
BULLISH +50
PDSB $40M
PDS Biotechnology Corporation
BULLISH +44
BCTX $40M
BriaCell Therapeutics Corp.
BULLISH +44
KROS $230M
Keros Therapeutics, Inc.
BULLISH +42
EVAX $20M
Evaxion Biotech A/S
BULLISH +42
BMNDF $40M
Biomind Labs Inc.
BULLISH +41
DRTS $1.3B
Alpha Tau Medical Ltd
BULLISH +40
BITRF $20M
Biotron Limited
BULLISH +40
QPTFF $10M
Quest PharmaTech Inc.
BULLISH +40
CURX $10M
Curanex Pharmaceuticals Inc Common Stock
BULLISH +40
ADAPY $10M
Adaptimmune Therapeutics plc
BULLISH +38
NKGN —
NKGen Biotech, Inc.
BULLISH +38
TRVN —
Trevena, Inc.
BULLISH +38
HALB —
Halberd Corporation
BULLISH +36
STTK $610M
Shattuck Labs, Inc.
BULLISH +34
ACIU $280M
AC Immune S.A.
BULLISH +34
LIANY $10M
LianMedical
BULLISH +34
ANIX $100M
Anixa Biosciences, Inc.
BULLISH +33
TXTM $10M
ProText Mobility, Inc.
BULLISH +33
PBM —
Psyence Biomedical Ltd.
BULLISH +31
NTLA $1.7B
Intellia Therapeutics, Inc.
LEAN BULL +27
ENTA $380M
Enanta Pharmaceuticals, Inc.
LEAN BULL +27
PLX $220M
Protalix BioTherapeutics, Inc.
LEAN BULL +27
CBUS $130M
Cibus, Inc.
LEAN BULL +27
HOWL $50M
Werewolf Therapeutics, Inc.
LEAN BULL +27
ACOG $140M
Alpha Cognition Inc
LEAN BULL +26
ZHCLF $20M
Zenith Capital Corp.
LEAN BULL +26
GLWLF $10M
Glow Lifetech Corp.
LEAN BULL +26
VIR $1.9B
Vir Biotechnology, Inc.
LEAN BULL +25
NYMXF —
Nymox Pharmaceutical Corporation
LEAN BULL +25
NNVC $30M
NanoViricides, Inc.
LEAN BULL +22
PHRRF —
PharmaTher Holdings Ltd.
LEAN BULL +20
KRSA $140M
Korsana Biosciences, Inc.
LEAN BULL +19
MNKD $1.2B
MannKind Corporation
LEAN BULL +18
ATNM $40M
Actinium Pharmaceuticals, Inc.
LEAN BULL +18
VTGN $10M
VistaGen Therapeutics, Inc.
LEAN BULL +18
TRAW $10M
Traws Pharma, Inc.
LEAN BULL +18
ASBP —
Aspire Biopharma Holdings, Inc.
LEAN BULL +18
NMTRQ —
9 Meters Biopharma, Inc.
LEAN BULL +18
HYFT $60M
MindWalk Holdings Corp.
LEAN BULL +17
VERU $40M
Veru Inc.
LEAN BULL +17
CNSP $10M
CNS Pharmaceuticals, Inc.
LEAN BULL +17
CUBT $10M
Curative Biotechnology, Inc.
LEAN BULL +16
APUS —
Apimeds Pharmaceuticals US, Inc
LEAN BULL +13
GNLX $110M
Genelux Corporation
LEAN BULL +11
HSTC $100M
HST Global, Inc.
LEAN BULL +11
RNTX $20M
Rein Therapeutics Inc.
LEAN BULL +11
BRAXF —
Braxia Scientific Corp.
LEAN BULL +11
BIXT —
Bioxytran, Inc.
LEAN BULL +11
NMLSF —
Restart Life Sciences Corp.
LEAN BULL +11
HRTX $70M
Heron Therapeutics, Inc.
LEAN BULL +10
MAZE $1.5B
Maze Therapeutics, Inc.
NEUTRAL +9
SPRO $70M
Spero Therapeutics, Inc.
NEUTRAL +9
AEON $10M
AEON Biopharma, Inc.
NEUTRAL +9
ORGS $10M
Orgenesis Inc.
NEUTRAL +9
CPMV —
Mosaic ImmunoEngineering Inc.
NEUTRAL +9
CAPR $510M
Capricor Therapeutics, Inc.
NEUTRAL +8
PBYI $480M
Puma Biotechnology, Inc.
NEUTRAL +8
DARE $10M
Dare Bioscience, Inc.
NEUTRAL +8
KPRX $10M
Kiora Pharmaceuticals, Inc.
NEUTRAL +7
COYA $110M
Coya Therapeutics, Inc.
NEUTRAL +6
AFMDQ —
Affimed N.V.
NEUTRAL +6
ANL $800M
Adlai Nortye Ltd.
NEUTRAL +5
CDIO $10M
Cardio Diagnostics Holdings, Inc.
NEUTRAL +5
CLGN —
CollPlant Biotechnologies Ltd.
NEUTRAL +3
OMER $1.4B
Omeros Corporation
NEUTRAL +2
SOLTF $720M
Nxera Pharma Co., Ltd.
NEUTRAL +2
MLLCF $150M
Molecular Partners AG
NEUTRAL +2
PRNAF $90M
Alterity Therapeutics Limited
NEUTRAL +2
OKYO $60M
OKYO Pharma Limited
NEUTRAL +2
CLNN $50M
Clene Inc.
NEUTRAL +1
KNTPF $110M
Kintor Pharmaceutical Limited
NEUTRAL 0
BXPHF $40M
Botanix Pharmaceuticals Limited
NEUTRAL 0
MMIRF $30M
MedMira Inc.
NEUTRAL 0
ENVB $10M
Enveric Biosciences, Inc.
NEUTRAL 0
GRI —
GRI Bio, Inc.
NEUTRAL 0
HLSQ —
Tessera Defense and Homeland Security Inc
N/A 0
QNTM $20M
Quantum BioPharma Ltd.
NEUTRAL -2
SIGY —
Sigyn Therapeutics, Inc.
NEUTRAL -2
PHMMF $1.6B
Pharma Mar, S.A.
NEUTRAL -3
INRLF $640M
Valneva SE
NEUTRAL -3
XLO $60M
Xilio Therapeutics, Inc.
NEUTRAL -4
CNTN $170M
Canton Strategic Holdings Inc
NEUTRAL -6
CBDG —
THC Farmaceuticals, Inc.
NEUTRAL -6
LIMNW —
Liminatus Pharma, Inc. Warrants
NEUTRAL -6
RBSH —
Rebus Holdings, Inc.
NEUTRAL -6
VRCI —
Verde Science, Inc.
NEUTRAL -6
HAVLF —
HAVN Life Sciences Inc.
NEUTRAL -6
VSTM $680M
Verastem, Inc.
NEUTRAL -7
INTI $20M
Inhibitor Therapeutics, Inc.
NEUTRAL -8
LIMN $10M
Liminatus Pharma, Inc. Class A Common Stock
NEUTRAL -8
VBIO $10M
Valion Bio, Inc.
NEUTRAL -8
MTNB —
Matinas BioPharma Holdings, Inc.
NEUTRAL -8
RARE $1.5B
Ultragenyx Pharmaceutical Inc.
NEUTRAL -9
TENX $50M
Tenax Therapeutics, Inc.
NEUTRAL -9
VRPX —
Virpax Pharmaceuticals, Inc.
NEUTRAL -9
RGIN —
Regenicin, Inc.
NEUTRAL -9
ONCO —
Onconetix, Inc.
NEUTRAL -9
SRNE —
Sorrento Therapeutics, Inc.
NEUTRAL -9
GLSI $250M
Greenwich LifeSciences, Inc.
LEAN BEAR -10
MDWD $170M
MediWound Ltd.
LEAN BEAR -10
ACRV $90M
Acrivon Therapeutics, Inc. Common Stock
LEAN BEAR -10
AURX $60M
Nuo Therapeutics, Inc.
LEAN BEAR -10
SGMOQ $60M
Sangamo Therapeutics, Inc.
LEAN BEAR -11
GWIN $230M
Glorywin Entertainment Group, Inc.
LEAN BEAR -12
CLYYF $10M
Celyad Oncology S.A.
LEAN BEAR -12
PBLA —
Panbela Therapeutics, Inc.
LEAN BEAR -12
MNOV $90M
MediciNova, Inc.
LEAN BEAR -13
PTIX —
Protagenic Therapeutics, Inc.
LEAN BEAR -13
KLDO —
Kaleido Biosciences, Inc.
LEAN BEAR -13
MENS $170M
Jyong Biotech Ltd. Ordinary Shares
LEAN BEAR -14
NVCT $580M
Nuvectis Pharma, Inc.
LEAN BEAR -15
INDP $270M
Indaptus Therapeutics, Inc.
LEAN BEAR -15
GLSHQ —
Gelesis Holdings, Inc.
LEAN BEAR -15
WINT —
Windtree Therapeutics, Inc.
LEAN BEAR -15
VINC —
Vincerx Pharma, Inc.
LEAN BEAR -15
XNCR $1.8B
Xencor, Inc.
LEAN BEAR -16
PROK $580M
ProKidney Corp.
LEAN BEAR -16
KTTA $20M
Pasithea Therapeutics Corp.
LEAN BEAR -16
CELZ —
Creative Medical Technology Holdings, Inc.
LEAN BEAR -16
MDXG $670M
MiMedx Group, Inc.
LEAN BEAR -18
XRTX —
XORTX Therapeutics Inc.
LEAN BEAR -18
DCOY —
Decoy Therapeutics Inc.
LEAN BEAR -18
FPMI —
FluoroPharma Medical, Inc.
LEAN BEAR -18
TLOG —
TetraLogic Pharmaceuticals Corporation
LEAN BEAR -18
CSPHF $1.2B
CStone Pharmaceuticals
LEAN BEAR -19
LYRA —
Lyra Therapeutics, Inc.
LEAN BEAR -19
BDRX —
Biodexa Pharmaceuticals Plc
LEAN BEAR -19
GNFTF $790M
Genfit S.a.
LEAN BEAR -20
ATOS $20M
Atossa Therapeutics, Inc.
LEAN BEAR -22
JAGX —
Jaguar Health, Inc.
LEAN BEAR -22
GBIM —
GlobeImmune, Inc.
LEAN BEAR -22
AMBS —
Amarantus BioScience Holdings, Inc.
LEAN BEAR -22
PBMWW —
Psyence Biomedical Ltd. Warrant
LEAN BEAR -22
RVLPQ —
RVL Pharmaceuticals plc
LEAN BEAR -23
GSTC —
GlobeStar Therapeutics Corporation
LEAN BEAR -23
DNAG —
DNAPrint Genomics, Inc.
LEAN BEAR -23
ATRA $90M
Atara Biotherapeutics, Inc.
LEAN BEAR -24
XBIT $70M
XBiotech Inc.
LEAN BEAR -24
VTIAF $50M
FamiCord AG
LEAN BEAR -24
ALGS $30M
Aligos Therapeutics, Inc.
LEAN BEAR -24
BPTH —
Bio-Path Holdings, Inc.
LEAN BEAR -24
CMRA —
Comera Life Sciences Holdings, Inc.
LEAN BEAR -24
SRBCF —
Sirona Biochem Corp.
LEAN BEAR -24
TBPH $880M
Theravance Biopharma Inc
LEAN BEAR -25
EQ $90M
Equillium, Inc.
LEAN BEAR -25
PTN $20M
Palatin Technologies, Inc.
LEAN BEAR -25
BOLT $10M
Bolt Biotherapeutics, Inc.
LEAN BEAR -25
SKYE $10M
Skye Bioscience, Inc.
LEAN BEAR -26
LSTA $10M
Lisata Therapeutics, Inc.
LEAN BEAR -26
PYPD $100M
PolyPid Ltd.
LEAN BEAR -27
PARD —
Poniard Pharmaceuticals, Inc.
LEAN BEAR -27
TVGN $30M
Tevogen Bio Holdings Inc.
LEAN BEAR -28
ALZN $10M
Alzamend Neuro Inc
LEAN BEAR -28
BPMUF $940M
Basilea Pharmaceutica AG
LEAN BEAR -29
ANNX $690M
Annexon, Inc.
BEARISH -31
SNTI $10M
Senti Biosciences, Inc.
BEARISH -31
CODX $10M
Co-Diagnostics, Inc.
BEARISH -31
ARTL —
Artelo Biosciences, Inc.
BEARISH -31
OGEN —
Oragenics, Inc.
BEARISH -31
BIOAF —
Bioasis Technologies Inc.
BEARISH -31
IPIX —
Innovation Pharmaceuticals Inc.
BEARISH -31
SLXN —
Silexion Therapeutics Ltd.
BEARISH -31
CSBR $70M
Champions Oncology, Inc.
BEARISH -32
ELUT $30M
Elutia Inc
BEARISH -32
LONA $20M
LeonaBio, Inc.
BEARISH -32
APVO —
Aptevo Therapeutics Inc.
BEARISH -32
NNLX —
NanoLogix, Inc.
BEARISH -32
MCET —
MultiCell Technologies, Inc.
BEARISH -32
SNBIF $1.3B
SanBio Company Limited
BEARISH -33
REPL $1.1B
Replimune Group, Inc.
BEARISH -33
GALT $260M
Galectin Therapeutics Inc.
BEARISH -33
SCNLF $150M
Scancell Holdings plc
BEARISH -33
RANI $50M
Rani Therapeutics Holdings, Inc.
BEARISH -33
REPCF —
RepliCel Life Sciences Inc.
BEARISH -33
PROT —
Proteonomix, Inc.
BEARISH -33
JUNS —
Jupiter Neurosciences, Inc.
BEARISH -33
FATE $270M
Fate Therapeutics, Inc.
BEARISH -34
ALEC $200M
Alector, Inc.
BEARISH -34
TELO $80M
Telomir Pharmaceuticals, Inc. Common Stock
BEARISH -34
ELOX $50M
Eloxx Pharmaceuticals, Inc.
BEARISH -34
ABVC $30M
ABVC BioPharma, Inc.
BEARISH -34
NRXBF $30M
NurExone Biologic Inc.
BEARISH -34
EMMA —
Emmaus Life Sciences, Inc.
BEARISH -34
CTNM $490M
Contineum Therapeutics, Inc.
BEARISH -35
ANVS $50M
Annovis Bio, Inc.
BEARISH -35
MDCLF $1.2B
MedinCell S.A.
BEARISH -38
PLYX $100M
Polaryx Therapeutics, Inc. Common Stock
BEARISH -38
POLBF $70M
Poolbeg Pharma PLC
BEARISH -38
BTAIQ —
BioXcel Therapeutics, Inc.
BEARISH -38
RVPH $10M
Reviva Pharmaceuticals Holdings, Inc.
BEARISH -40
RCAR —
RenovaCare, Inc.
BEARISH -40
ARDS —
Aridis Pharmaceuticals, Inc.
BEARISH -40
NNBP —
Nanobac Pharmaceuticals, Incorporated
BEARISH -40
EHOS —
Ehouse Global, Inc.
BEARISH -40
IMVIF —
IMV Inc.
BEARISH -40
SNANF $30M
Sona Nanotech Inc.
BEARISH -41
AIMD $10M
Ainos, Inc.
BEARISH -41
CNBX —
CNBX Pharmaceuticals Inc.
BEARISH -41
AFFY —
Affymax, Inc.
BEARISH -41
CARM —
Carisma Therapeutics, Inc.
BEARISH -41
NURPF $1.8B
Neuren Pharmaceuticals Limited
BEARISH -42
AVBP $1.3B
ArriVent BioPharma, Inc.
BEARISH -42
SLNCF $570M
Silence Therapeutics plc
BEARISH -42
AVIR $410M
Atea Pharmaceuticals, Inc.
BEARISH -42
WHWK $210M
Whitehawk Therapeutics Inc
BEARISH -42
VTVT $80M
vTv Therapeutics Inc.
BEARISH -42
CNTB $60M
Connect Biopharma Holdings Limited
BEARISH -42
FNCHQ $20M
Finch Therapeutics Group, Inc.
BEARISH -42
IMUC $20M
EOM Pharmaceuticals Holdings, Inc.
BEARISH -42
SCNI —
Scinai Immunotherapeutics Ltd.
BEARISH -42
ATXI —
Avenue Therapeutics, Inc.
BEARISH -42
MLECW —
Moolec Science S.A.
BEARISH -42
ORIC $1.3B
ORIC Pharmaceuticals, Inc.
BEARISH -43
IVVD $240M
Invivyd, Inc.
BEARISH -43
SNNAQ —
Sienna Biopharmaceuticals, Inc.
BEARISH -43
BTAX —
Biostax Corp.
BEARISH -43
ALPS $70M
Alps Group Inc
BEARISH -44
ANEB $10M
Anebulo Pharmaceuticals, Inc.
BEARISH -44
IRD $380M
Opus Genetics, Inc.
BEARISH -47
AOBI —
American Oriental Bioengineering, Inc.
BEARISH -47
DYAI $20M
Dyadic International, Inc.
BEARISH -48
TOVX $10M
Theriva Biologics, Inc.
BEARISH -48
OXBOF —
Oxford BioDynamics Plc
BEARISH -48
PHGUF $780M
Pharming Group N.V.
BEARISH -49
CDXS $150M
Codexis, Inc.
BEARISH -49
THER —
Theralink Technologies, Inc.
BEARISH -49
PSYBF —
PsyBio Therapeutics Corp
BEARISH -49
LIFS —
Life Stem Genetics Inc.
BEARISH -49
HLUN —
HEALTHeUNIVERSE, Inc.
BEARISH -49
PZRXQ —
PhaseRx, Inc.
BEARISH -49
NTII —
Neurobiological Technologies, Inc.
BEARISH -49
AMPE —
Ampio Pharmaceuticals, Inc.
BEARISH -49
MRPI —
Mera Pharmaceuticals, Inc.
BEARISH -49
MRZM —
Marizyme, Inc.
BEARISH -49
ZBIO $1.8B
Zenas BioPharma, Inc.
BEARISH -50
SGP $830M
SpyGlass Pharma, Inc. Common Stock
BEARISH -50
ACHV $740M
Achieve Life Sciences, Inc.
BEARISH -50
ORMP $180M
Oramed Pharmaceuticals Inc.
BEARISH -50
ENTX $140M
Entera Bio Ltd.
BEARISH -50
ADCT $140M
ADC Therapeutics S.A.
BEARISH -50
OTLK $110M
Outlook Therapeutics, Inc.
BEARISH -50
ICCC $90M
ImmuCell Corporation
BEARISH -50
TPST $10M
Tempest Therapeutics, Inc.
BEARISH -50
MTVA $10M
MetaVia Inc.
BEARISH -50
LOBEF $10M
Lobe Sciences Ltd.
BEARISH -50
NBIO —
Nascent Biotech, Inc.
BEARISH -50
HCWB —
HCW Biologics Inc.
BEARISH -50
BSSP —
Baseline Productions, Inc.
BEARISH -50
SPRC —
SciSparc Ltd.
BEARISH -50
INFIQ —
Infinity Pharmaceuticals, Inc.
BEARISH -50
EXOZ $50M
eXoZymes, Inc.
BEARISH -51
NIKI —
Niki BioSolutions, Inc.
BEARISH -51
VBIZF $400M
Viva Biotech Holdings
BEARISH -52
BBIXF $50M
Bonus Biogroup Ltd.
BEARISH -52
NICXF $30M
Nicox S.A.
BEARISH -52
HOPHF $20M
Hemogenyx Pharmaceuticals Plc
BEARISH -52
LVCLF $20M
Algorae Pharmaceuticals Limited
BEARISH -52
BIVI $10M
BioVie Inc.
BEARISH -52
NSHSF —
NanoSphere Health Sciences Inc.
BEARISH -52
CHNXF —
ChitogenX Inc.
BEARISH -52
FORU —
ForU Holdings, Inc.
BEARISH -52
XSNX —
NovAccess Global Inc.
BEARISH -52
AVCTF $440M
Avacta Group Plc
BEARISH -53
HNSBF $330M
Hansa Biopharma AB
BEARISH -53
FBIOP $130M
Fortress Biotech, Inc.
BEARISH -53
FHTX $120M
Foghorn Therapeutics Inc.
BEARISH -53
VICP $20M
Vicapsys Life Sciences, Inc.
BEARISH -53
RLFTY —
MindMaze Therapeutics Holding S.A.
BEARISH -53
ELTX $40M
Elicio Therapeutics, Inc.
BEARISH -56
SEOVF $30M
Sernova Corp.
BEARISH -56
USRM —
U.S. Stem Cell, Inc.
BEARISH -56
JANX $1.0B
Janux Therapeutics, Inc.
BEARISH -58
STRO $150M
Sutro Biopharma, Inc.
BEARISH -58
IBIO $70M
iBio, Inc.
BEARISH -58
TIL $50M
Instil Bio, Inc.
BEARISH -58
IGC $30M
IGC Pharma, Inc.
BEARISH -58
ACTU $20M
Actuate Therapeutics Inc
BEARISH -58
PVCT $20M
Provectus Biopharmaceuticals, Inc.
BEARISH -58
TCRX $20M
TScan Therapeutics, Inc.
BEARISH -58
NCNA $10M
NuCana plc
BEARISH -58
GDTC $10M
CytoMed Therapeutics Limited
BEARISH -58
BVAXF —
BioVaxys Technology Corp.
BEARISH -58
RNUGF —
ReNeuron Group plc
BEARISH -58
CFRXQ —
ContraFect Corp.
BEARISH -58
ARNI —
Arno Therapeutics, Inc.
BEARISH -58
LIPO —
Lipella Pharmaceuticals Inc.
BEARISH -58
PANC —
Panacos Pharmaceuticals, Inc.
BEARISH -58
CDXI —
Cardax, Inc.
BEARISH -58
PFND —
Pathfinder Cell Therapy, Inc.
BEARISH -58
PMCB —
PharmaCyte Biotech, Inc.
BEARISH -58
KNBIF —
Kane Biotech Inc.
BEARISH -58
SYVC —
Synovics Pharmaceuticals, Inc.
BEARISH -58
ADYX —
Adynxx, Inc.
BEARISH -58
CASIF —
CASI Pharmaceuticals, Inc.
BEARISH -58
EVGN —
Evogene Ltd.
BEARISH -58
CBIO $530M
Crescent Biopharma, Inc.
BEARISH -59
EDIT $400M
Editas Medicine, Inc.
BEARISH -59
MGNX $230M
MacroGenics, Inc.
BEARISH -59
VANI $110M
Vivani Medical, Inc.
BEARISH -59
ACHFF $40M
Arch Biopartners Inc.
BEARISH -59
COCP $20M
Cocrystal Pharma, Inc.
BEARISH -59
IMRN $10M
Immuron Limited
BEARISH -59
QNCX $10M
Quince Therapeutics, Inc.
BEARISH -59
SYBX $10M
Synlogic, Inc.
BEARISH -59
PPCB —
Propanc Biopharma, Inc.
BEARISH -59
NCEL —
NewcelX Ltd.
BEARISH -59
ISCO —
International Stem Cell Corporation
BEARISH -59
AAGH —
America Great Health
BEARISH -59
RGBPP —
Regen BioPharma, Inc.
BEARISH -59
FGHQF $350M
Frontage Holdings Corporation
BEARISH -60
SGMT $300M
Sagimet Biosciences Inc.
BEARISH -60
BRIBF $90M
Brii Biosciences Limited
BEARISH -60
SYGGF —
Synairgen plc
BEARISH -60
GHRS $1.6B
GH Research PLC
BEARISH -62
LXRX $810M
Lexicon Pharmaceuticals, Inc.
BEARISH -62
ACRS $610M
Aclaris Therapeutics, Inc.
BEARISH -62
XBIO $10M
Xenetic Biosciences, Inc.
BEARISH -62
OBX $10M
Obsidian Therapeutics Inc.
BEARISH -65
SYBE —
SYBLEU Inc
BEARISH -65
SQZB —
SQZ Biotechnologies Company
BEARISH -65
STOK $1.6B
Stoke Therapeutics, Inc.
BEARISH -66
IMTX $1.0B
Immatics N.V.
BEARISH -66
ODTX $1.0B
Odyssey Therapeutics, Inc.
BEARISH -66
SVRA $990M
Savara Inc.
BEARISH -66
DSGN $770M
Design Therapeutics, Inc.
BEARISH -66
RZLT $390M
Rezolute, Inc.
BEARISH -66
OCGN $350M
Ocugen, Inc.
BEARISH -66
CAMP $250M
CAMP4 Therapeutics Corporation
BEARISH -66
RNAC $220M
Cartesian Therapeutics, Inc.
BEARISH -66
APLMW $160M
Apollomics, Inc.
BEARISH -66
ARMP $130M
Armata Pharmaceuticals, Inc.
BEARISH -66
BDTX $110M
Black Diamond Therapeutics, Inc.
BEARISH -66
GOSS $70M
Gossamer Bio, Inc.
BEARISH -66
OSTX $70M
OS Therapies Incorporated
BEARISH -66
INNMF $40M
Amplia Therapeutics Limited
BEARISH -66
RVXCF $20M
Resverlogix Corp.
BEARISH -66
AIM $10M
AIM ImmunoTech Inc.
BEARISH -66
KALA $10M
KALA BIO, Inc.
BEARISH -66
HIND $10M
Vyome Holdings, Inc.
BEARISH -66
MVMDF $10M
The More Life Company Corp.
BEARISH -66
TSOI —
Therapeutic Solutions International, Inc.
BEARISH -66
CANF —
Can-Fite BioPharma Ltd.
BEARISH -66
MRES —
Institute of Biomedical Research Corp.
BEARISH -66
SCPX —
Scorpius Holdings, Inc.
BEARISH -66
GNPX —
Genprex, Inc.
BEARISH -66
STAB —
Statera Biopharma, Inc.
BEARISH -66
CMND —
Clearmind Medicine Inc.
BEARISH -66
APLIF —
Appili Therapeutics Inc
BEARISH -66
HESG —
Health Sciences Group, Inc.
BEARISH -66
CEROW —
CERo Therapeutics Holdings, Inc.
BEARISH -66
SEPN $1.7B
Septerna Inc
BEARISH -68
FDMT $710M
4D Molecular Therapeutics, Inc.
BEARISH -68
EPRX $240M
Eupraxia Pharmaceuticals Inc.
BEARISH -68
NKTX $180M
Nkarta, Inc.
BEARISH -68
IBO $50M
Impact BioMedical Inc.
BEARISH -68
IXHL $40M
Incannex Healthcare Limited
BEARISH -68
ERNAW —
Ernexa Therapeutics Inc. Warrants
BEARISH -68
AMGXF $140M
AnGes, Inc.
BEARISH -69
ATRX —
Adhera Therapeutics Inc
BEARISH -69
IMMB —
Immunotech Laboratories, Inc.
BEARISH -69
MYMX —
Mymetics Corporation
BEARISH -69
NWPHF $420M
Newron Pharmaceuticals S.p.A.
BEARISH -71
ARCT $370M
Arcturus Therapeutics Holdings Inc.
BEARISH -73
APRE $10M
Aprea Therapeutics, Inc.
BEARISH -73
ENSC $10M
Ensysce Biosciences, Inc.
BEARISH -73
SYRS —
Syros Pharmaceuticals, Inc.
BEARISH -73
VAXX —
Vaxxinity, Inc.
BEARISH -73
DVHGF $20M
Devonian Health Group Inc.
BEARISH -74
MDCX $10M
Medicus Pharma Ltd. Common Stock
BEARISH -74
FAMDF —
Futura Medical plc
BEARISH -74
OCEA —
Ocean Biomedical, Inc.
BEARISH -74
BHVN $1.9B
Biohaven Ltd.
BEARISH -75
PVLA $1.9B
Palvella Therapeutics, Inc.
BEARISH -75
TYRA $1.2B
Tyra Biosciences, Inc.
BEARISH -75
VOR $1.0B
Vor Biopharma Inc.
BEARISH -75
ABUS $880M
Arbutus Biopharma Corp
BEARISH -75
SLBT $880M
SL Science Holding Ltd
BEARISH -75
EIKN $400M
Eikon Therapeutics, Inc. Common Stock
BEARISH -75
CLVLF $290M
Clinuvel Pharmaceuticals Limited
BEARISH -75
UPB $270M
Upstream Bio, Inc.
BEARISH -75
TRDA $210M
Entrada Therapeutics, Inc.
BEARISH -75
ELDN $190M
Eledon Pharmaceuticals, Inc.
BEARISH -75
DTIL $170M
Precision BioSciences, Inc.
BEARISH -75
NRXP $130M
NRx Pharmaceuticals, Inc.
BEARISH -75
HURA $120M
TuHURA Biosciences, Inc.
BEARISH -75
ADAG $110M
Adagene Inc.
BEARISH -75
AARD $110M
Aardvark Therapeutics, Inc. Common Stock
BEARISH -75
KRRO $100M
Korro Bio, Inc.
BEARISH -75
RNXT $70M
RenovoRx, Inc.
BEARISH -75
BOLD $60M
Boundless Bio, Inc.
BEARISH -75
INMB $50M
INmune Bio, Inc.
BEARISH -75
NDTP $40M
NDT Pharmaceuticals Inc.
BEARISH -75
TELIF $20M
Telescope Innovations Corp.
BEARISH -75
NEUP $20M
Neuphoria Therapeutics Inc.
BEARISH -75
KPTI $20M
Karyopharm Therapeutics Inc.
BEARISH -75
ALLR $20M
Allarity Therapeutics, Inc.
BEARISH -75
MDNAF $20M
Medicenna Therapeutics Corp.
BEARISH -75
PHYOF $10M
IXICO plc
BEARISH -75
CTXR $10M
Citius Pharmaceuticals, Inc.
BEARISH -75
PLRZ $10M
Polyrizon Ltd.
BEARISH -75
ENGNW $10M
enGene Holdings Inc. Warrants
BEARISH -75
ADIL $10M
Adial Pharmaceuticals, Inc.
BEARISH -75
NRSN $10M
NeuroSense Therapeutics Ltd.
BEARISH -75
SNGX $10M
Soligenix, Inc.
BEARISH -75
GTBP $10M
GT Biopharma, Inc.
BEARISH -75
HTDS —
Hard to Treat Diseases Inc.
BEARISH -75
CALA —
Calithera Biosciences, Inc.
BEARISH -75
EVLO —
Evelo Biosciences, Inc.
BEARISH -75
NTRR —
Neutra Corp.
BEARISH -75
VRAX —
Virax Biolabs Group Limited
BEARISH -75
XENO —
Xeno Transplants Corporation
BEARISH -75
EFTR —
eFFECTOR Therapeutics, Inc.
BEARISH -75
RMTG —
Regenerative Medical Technology Group Inc.
BEARISH -75
CHMMF —
Chimeric Therapeutics Limited
BEARISH -75
IDRSF $1.4B
Idorsia Ltd
BEARISH -78
CGEM $950M
Cullinan Therapeutics, Inc.
BEARISH -78
JBIO $860M
Jade Biosciences, Inc.
BEARISH -78
MNPR $520M
Monopar Therapeutics Inc.
BEARISH -78
ASMB $450M
Assembly Biosciences, Inc.
BEARISH -78
ABEO $290M
Abeona Therapeutics Inc.
BEARISH -78
PRQR $170M
ProQR Therapeutics N.V.
BEARISH -78
IMUX $110M
Immunic, Inc.
BEARISH -78
BMEA $90M
Biomea Fusion, Inc.
BEARISH -78
PMN $80M
ProMIS Neurosciences, Inc.
BEARISH -78
AVEFF $20M
Avecho Biotechnology Limited
BEARISH -78
CMMB $10M
Chemomab Therapeutics Ltd.
BEARISH -78
SILO —
Silo Pharma, Inc.
BEARISH -78
OZYMF —
Strategic Partners A/S
BEARISH -78
ANTH —
Anthera Pharmaceuticals, Inc.
BEARISH -78
GNLKQ —
GeneLink, Inc.
BEARISH -78
GLABF —
Gemina Laboratories Ltd.
BEARISH -78
MAJI —
Nextel Medical Corp.
BEARISH -80
SNDX $1.6B
Syndax Pharmaceuticals, Inc.
BEARISH -82
HBMHF $1.3B
HBM Holdings Limited
BEARISH -82
ARDX $830M
Ardelyx, Inc.
BEARISH -82
LXEO $280M
Lexeo Therapeutics, Inc. Common Stock
BEARISH -82
BOVNF $220M
BioInvent International AB (publ)
BEARISH -82
EDSA $40M
Edesa Biotech, Inc.
BEARISH -82
CNTX $30M
Context Therapeutics Inc.
BEARISH -82
CLCS $30M
Cell Source, Inc.
BEARISH -82
NAVBQ —
Navidea Biopharmaceuticals, Inc.
BEARISH -82
RNAZ —
TransCode Therapeutics, Inc.
BEARISH -82
CLDI —
Calidi Biotherapeutics, Inc.
BEARISH -82
ELAB —
PMGC Holdings Inc.
BEARISH -82
RADX —
Radiopharm Theranostics Limited
BEARISH -82
AGTX —
Agentix Corp.
BEARISH -82
PPBT —
Purple Biotech Ltd.
BEARISH -82
MYNDF —
MYND Life Sciences Inc.
BEARISH -82
ZLDAF —
Zelira Therapeutics Limited
BEARISH -82
ADXN —
Addex Therapeutics Ltd
BEARISH -82
ENDV —
Endonovo Therapeutics, Inc.
BEARISH -82
PREDQ —
Predictive Discovery Limited
BEARISH -82
ARUXF —
Acrux Limited
BEARISH -82
ACUT —
Accustem Sciences Inc.
BEARISH -82
SEPSF —
Asep Medical Holdings Inc
BEARISH -82
AGIO $1.9B
Agios Pharmaceuticals, Inc.
BEARISH -84
ZYME $1.9B
Zymeworks Inc.
BEARISH -84
NUVB $1.8B
Nuvation Bio Inc.
BEARISH -84
CMPS $1.6B
COMPASS Pathways plc
BEARISH -84
IMCR $1.5B
Immunocore Holdings plc
BEARISH -84
TSHA $1.5B
Taysha Gene Therapies, Inc.
BEARISH -84
INBX $1.4B
Inhibrx Biosciences Inc.
BEARISH -84
NBTX $1.3B
Nanobiotix S.A.
BEARISH -84
KURA $950M
Kura Oncology, Inc.
BEARISH -84
CADL $750M
Candel Therapeutics, Inc.
BEARISH -84
ZVRA $590M
Zevra Therapeutics, Inc.
BEARISH -84
PRME $540M
Prime Medicine, Inc.
BEARISH -84
AUTL $470M
Autolus Therapeutics plc
BEARISH -84
OVID $440M
Ovid Therapeutics Inc.
BEARISH -84
NGNE $410M
Neurogene Inc.
BEARISH -84
CCCC $330M
C4 Therapeutics, Inc.
BEARISH -84
CYDY $270M
CytoDyn Inc.
BEARISH -84
IFRX $250M
InflaRx N.V.
BEARISH -84
CGEN $220M
Compugen Ltd.
BEARISH -84
CUE $190M
Cue Biopharma, Inc.
BEARISH -84
IPHA $150M
Innate Pharma S.A.
BEARISH -84
ABOS $150M
Acumen Pharmaceuticals, Inc.
BEARISH -84
PYXS $140M
Pyxis Oncology, Inc.
BEARISH -84
MXCT $110M
MaxCyte, Inc.
BEARISH -84
VRCA $80M
Verrica Pharmaceuticals Inc.
BEARISH -84
BETRF $30M
BetterLife Pharma Inc.
BEARISH -84
LPCN $20M
Lipocine Inc.
BEARISH -84
KZIA $20M
Kazia Therapeutics Ltd ADR
BEARISH -84
AKTX $10M
Akari Therapeutics, Plc
BEARISH -84
IMNN $10M
Imunon, Inc.
BEARISH -84
EVFM —
Evofem Biosciences, Inc.
BEARISH -84
IMNM $2.0B
Immunome, Inc.
BEARISH -87
TRVI $2.0B
Trevi Therapeutics, Inc.
BEARISH -87
QURE $1.6B
uniQure N.V.
BEARISH -87
RAPP $1.5B
Rapport Therapeutics, Inc. Common Stock
BEARISH -87
OCUL $1.5B
Ocular Therapeutix, Inc.
BEARISH -87
ANAB $1.4B
AnaptysBio, Inc.
BEARISH -87
NKTR $1.2B
Nektar Therapeutics
BEARISH -87
BCAX $1.2B
Bicara Therapeutics Inc. Common Stock
BEARISH -87
LBRX $1.1B
LB Pharmaceuticals Inc Common Stock
BEARISH -87
MGTX $1.0B
MeiraGTx Holdings plc
BEARISH -87
AKTS $990M
Aktis Oncology, Inc.
BEARISH -87
ANRO $870M
Alto Neuroscience, Inc.
BEARISH -87
AVTX $790M
Avalo Therapeutics, Inc.
BEARISH -87
SLDB $670M
Solid Biosciences Inc.
BEARISH -87
CLYM $630M
Climb Bio, Inc.
BEARISH -87
AURA $630M
Aura Biosciences, Inc.
BEARISH -87
IMMX $530M
Immix Biopharma, Inc.
BEARISH -87
TECX $430M
Tectonic Therapeutic, Inc.
BEARISH -87
FENC $350M
Fennec Pharmaceuticals Inc.
BEARISH -87
ARTV $330M
Artiva Biotherapeutics, Inc.
BEARISH -87
SPHDF $270M
Santhera Pharmaceuticals Holding AG
BEARISH -87
IKT $260M
Inhibikase Therapeutics, Inc.
BEARISH -87
QTTB $240M
Q32 Bio Inc.
BEARISH -87
PRLD $210M
Prelude Therapeutics Incorporated
BEARISH -87
ZNTL $180M
Zentalis Pharmaceuticals, Inc.
BEARISH -87
ALXO $160M
ALX Oncology Holdings Inc.
BEARISH -87
CRBP $110M
Corbus Pharmaceuticals Holdings, Inc.
BEARISH -87
CRDF $90M
Cardiff Oncology, Inc.
BEARISH -87
ACET $60M
Adicet Bio, Inc.
BEARISH -87
SER $30M
Serina Therapeutics, Inc.
BEARISH -87
XTLB —
XTL Biopharmaceuticals Ltd.
BEARISH -87
HXBM —
Helix BioMedix, Inc.
BEARISH -87
CDT —
CDT Equity Inc.
BEARISH -87
BRVE $1.5B
Braveheart Bio, Inc.
BEARISH -90
APMD $860M
Apnimed, Inc.
BEARISH -90
GENSF $1.9B
Genus plc
BEARISH -91
COAG $1.4B
Hemab Therapeutics Holdings, Inc. Common Stock
BEARISH -91
KLRA $1.4B
Kailera Therapeutics, Inc.
BEARISH -91
KARD $1.3B
Kardigan, Inc.
BEARISH -91
AVLN $1.2B
Avalyn Pharma Inc. Common Stock
BEARISH -91
SPTX $990M
Seaport Therapeutics, Inc. Common Stock
BEARISH -91
MLTX $960M
MoonLake Immunotherapeutics
BEARISH -91
WVE $740M
Wave Life Sciences Ltd.
BEARISH -91
FTH $730M
Faeth Therapeutics, Inc.
BEARISH -91
OCS $500M
Oculis Holding AG
BEARISH -91
DRUG $500M
Bright Minds Biosciences Inc.
BEARISH -91
PRTA $440M
Prothena Corporation plc
BEARISH -91
MPLT $420M
MapLight Therapeutics, Inc.
BEARISH -91
ZURA $390M
Zura Bio Limited
BEARISH -91
CABA $330M
Cabaletta Bio, Inc.
BEARISH -91
BBOT $310M
BridgeBio Oncology Therapeutics Inc.
BEARISH -91
FULC $280M
Fulcrum Therapeutics, Inc.
BEARISH -91
SABS $270M
SAB Biotherapeutics, Inc.
BEARISH -91
NWBO $250M
Northwest Biotherapeutics, Inc.
BEARISH -91
PALI $250M
Palisade Bio, Inc.
BEARISH -91
HLOSF $240M
Healios K.K.
BEARISH -91
AKBA $230M
Akebia Therapeutics, Inc.
BEARISH -91
NAGE $220M
Niagen Bioscience Inc
BEARISH -91
YARW $210M
Yarrow Bioscience Inc
BEARISH -91
VRXA $160M
Veraxa Biotech Holding AG
BEARISH -91
NBP $160M
NovaBridge Biosciences
BEARISH -91
CMPX $150M
Compass Therapeutics, Inc.
BEARISH -91
IMRX $150M
Immuneering Corporation
BEARISH -91
TNXP $140M
Tonix Pharmaceuticals Holding Corp.
BEARISH -91
CLLS $140M
Cellectis S.A.
BEARISH -91
MIST $100M
Milestone Pharmaceuticals Inc.
BEARISH -91
ORPOF $100M
OSE Immunotherapeutics S.A.
BEARISH -91
HUMA $90M
Humacyte, Inc.
BEARISH -91
INO $80M
Inovio Pharmaceuticals, Inc.
BEARISH -91
JWCTF $80M
JW (Cayman) Therapeutics Co. Ltd
BEARISH -91
GANX $70M
Gain Therapeutics, Inc.
BEARISH -91
RECEF $70M
Recce Pharmaceuticals Ltd
BEARISH -91
MAIA $70M
MAIA Biotechnology, Inc.
BEARISH -91
KLRS $60M
Kalaris Therapeutics Inc
BEARISH -91
DWTX $50M
Dogwood Therapeutics, Inc.
BEARISH -91
IMA $50M
ImageneBio Inc
BEARISH -91
BSEM $50M
BioStem Technologies, Inc.
BEARISH -91
GRCE $30M
Grace Therapeutics, Inc.
BEARISH -91
ESLA $20M
Estrella Immunopharma, Inc.
BEARISH -91
NXTC $20M
NextCure, Inc.
BEARISH -91
DTCFF $20M
Defence Therapeutics Inc.
BEARISH -91
MRKR $20M
Marker Therapeutics, Inc.
BEARISH -91
LGVN $10M
Longeveron Inc.
BEARISH -91
CKDXF $10M
Ceryvyn Therapeutics Limited
BEARISH -91
CALC $10M
CalciMedica, Inc.
BEARISH -91
INTS $10M
Intensity Therapeutics, Inc.
BEARISH -91
XCUR $10M
Exicure, Inc.
BEARISH -91
OPTBF $10M
OptiBiotix Health PLC
BEARISH -91
GSGTF $10M
GenSight Biologics S.A.
BEARISH -91
IUGNF $10M
Imugene Limited
BEARISH -91
PLUR $10M
Pluri Inc.
BEARISH -91
ZEOX $10M
Zeo ScientifiX, Inc.
BEARISH -91
BLRX $10M
BioLineRx Ltd.
BEARISH -91
QNRX $10M
Quoin Pharmaceuticals, Ltd.
BEARISH -91
LNAI $10M
Lunai Bioworks Inc.
BEARISH -91
ENLV $10M
Enlivex Therapeutics Ltd.
BEARISH -91
PXXLF $10M
Poxel S.A.
BEARISH -91
FNAM —
Evolutionary Genomics, Inc.
BEARISH -91
KAPA —
Kairos Pharma, Ltd.
BEARISH -91
SUVZ —
Suvanza Pharma, LLC
BEARISH -91
VSBC —
VitaSpring Biomedical Co. Ltd.
BEARISH -91
PXMD —
PaxMedica, Inc. Common Stock
BEARISH -91
ENZC —
Enzolytics Inc.
BEARISH -91
LEXX —
Lexaria Bioscience Corp.
BEARISH -91
CVKD —
Cadrenal Therapeutics, Inc. Common Stock
BEARISH -91
VRXAW —
Veraxa Biotech AG
BEARISH -91
PCSA —
Processa Pharmaceuticals, Inc.
BEARISH -91
BNIGF —
Beroni Group Limited
BEARISH -91
WSNAF —
Wesana Health Holdings Inc.
BEARISH -91
MBAI —
MBody AI Ltd.
BEARISH -91
NBRVF —
Nabriva Therapeutics plc
BEARISH -91
IBOGF —
Universal Ibogaine Inc.
BEARISH -91
HMGN —
Hemagen Diagnostics, Inc.
BEARISH -91
RASP —
Actavia Life Sciences, Inc.
BEARISH -91
TCRT —
Alaunos Therapeutics, Inc.
BEARISH -91
BICTF —
Biocure Technology Inc.
BEARISH -91
BBLG —
Bone Biologics Corporation
BEARISH -91
RGRX —
RegeneRx Biopharmaceuticals, Inc.
BEARISH -91
TNGNQ —
Tengion, Inc.
BEARISH -91
FBLG —
FibroBiologics, Inc. Common Stock
BEARISH -91
ADTX —
Aditxt, Inc.
BEARISH -91
ITMC —
Itoco Inc.
BEARISH -91
BPTSY —
Biophytis S.A.
BEARISH -91
VPRO —
Viropro Inc.
BEARISH -91
DRMA —
Dermata Therapeutics, Inc.
BEARISH -91
ONCSQ —
OncoSec Medical Incorporated
BEARISH -91
VIVS —
VivoSim Labs, Inc.
BEARISH -91
SRPT $1.9B
Sarepta Therapeutics, Inc.
BEARISH -100
MESO $1.8B
Mesoblast Limited
BEARISH -100
GENB $1.8B
Generate Biomedicines, Inc.
BEARISH -100
GPCR $1.6B
Structure Therapeutics Inc.
BEARISH -100
INVA $1.5B
Innoviva, Inc.
BEARISH -100
ASPHF $1.4B
Ascentage Pharma Group International
BEARISH -100
DMRA $1.3B
Damora Therapeutics, Inc.
BEARISH -100
TRAX $1.2B
First Tracks Biotherapeutics Inc
BEARISH -100
ASCLF $1.1B
Ascletis Pharma Inc.
BEARISH -100
CRVS $920M
Corvus Pharmaceuticals, Inc.
BEARISH -100
GLUE $890M
Monte Rosa Therapeutics, Inc.
BEARISH -100
ALMS $850M
Alumis Inc.
BEARISH -100
SANA $800M
Sana Biotechnology, Inc.
BEARISH -100
GERN $770M
Geron Corporation
BEARISH -100
IVEVF $760M
Inventiva S.A.
BEARISH -100
ATTO $740M
Attovia Therapeutics, Inc.
BEARISH -100
OLMA $720M
Olema Pharmaceuticals, Inc.
BEARISH -100
BLSM $570M
BlossomHill Therapeutics, Inc.
BEARISH -100
CRMD $560M
CorMedix Inc.
BEARISH -100
CTMX $560M
CytomX Therapeutics, Inc.
BEARISH -100
PHAT $560M
Phathom Pharmaceuticals, Inc.
BEARISH -100
ALT $530M
Altimmune, Inc.
BEARISH -100
ALLO $520M
Allogene Therapeutics, Inc.
BEARISH -100
ARVN $480M
Arvinas, Inc.
BEARISH -100
AGMB $420M
AgomAb Therapeutics N.V. American Depositary Shares
BEARISH -100
SPRY $400M
ARS Pharmaceuticals, Inc.
BEARISH -100
PTCHF $380M
PureTech Health plc
BEARISH -100
KYTX $380M
Kyverna Therapeutics, Inc.
BEARISH -100
RLMD $380M
Relmada Therapeutics, Inc.
BEARISH -100
RGNX $380M
REGENXBIO Inc.
BEARISH -100
BNTC $310M
Benitec Biopharma Inc.
BEARISH -100
LRMR $310M
Larimar Therapeutics, Inc.
BEARISH -100
VNDA $280M
Vanda Pharmaceuticals Inc.
BEARISH -100
RCKT $280M
Rocket Pharmaceuticals, Inc.
BEARISH -100
IPSC $280M
Century Therapeutics, Inc.
BEARISH -100
EYPT $270M
EyePoint Pharmaceuticals, Inc.
BEARISH -100
XFOR $270M
X4 Pharmaceuticals, Inc.
BEARISH -100
SCTX $270M
Scribe Therapeutics Inc.
BEARISH -100
ORYZF $250M
Oryzon Genomics S.A.
BEARISH -100
DBVT $250M
DBV Technologies S.A.
BEARISH -100
VOGX $250M
Vogenx Inc.
BEARISH -100
BIOA $250M
BioAge Labs Inc.
BEARISH -100
EVMN $250M
Evommune, Inc.
BEARISH -100
LYEL $230M
Lyell Immunopharma, Inc.
BEARISH -100
BCYC $230M
Bicycle Therapeutics plc
BEARISH -100
LCTX $230M
Lineage Cell Therapeutics, Inc.
BEARISH -100
SION $220M
Sionna Therapeutics, Inc.
BEARISH -100
CHRS $180M
Coherus Oncology, Inc.
BEARISH -100
AVXL $170M
Anavex Life Sciences Corp.
BEARISH -100
PEPG $160M
PepGen Inc.
BEARISH -100
VYGR $150M
Voyager Therapeutics, Inc.
BEARISH -100
TARA $150M
Protara Therapeutics, Inc.
BEARISH -100
NGEN $150M
NervGen Pharma Corp. Common stock
BEARISH -100
NERV $150M
Minerva Neurosciences, Inc.
BEARISH -100
SPRB $130M
Spruce Biosciences, Inc.
BEARISH -100
RNA $130M
Atrium Therapeutics, Inc.
BEARISH -100
CRBU $120M
Caribou Biosciences, Inc.
BEARISH -100
TNYA $120M
Tenaya Therapeutics, Inc.
BEARISH -100
VXRT $110M
Vaxart, Inc.
BEARISH -100
UNCY $110M
Unicycive Therapeutics, Inc.
BEARISH -100
LENZ $110M
LENZ Therapeutics, Inc.
BEARISH -100
OKUR $100M
OnKure Therapeutics, Inc.
BEARISH -100
NMRA $90M
Neumora Therapeutics, Inc. Common Stock
BEARISH -100
CNXU $80M
Conexeu Sciences Inc.
BEARISH -100
CGTX $80M
Cognition Therapeutics, Inc.
BEARISH -100
NTHI $80M
Neonc Technologies Holdings, Inc.
BEARISH -100
ALDX $70M
Aldeyra The
BEARISH -100
PTHS $70M
Pelthos Therapeutics Inc.
BEARISH -100
CING $60M
Cingulate Inc.
BEARISH -100
PLRX $60M
Pliant Therapeutics, Inc.
BEARISH -100
GUTS $60M
Fractyl Health, Inc.
BEARISH -100
ONCY $60M
Oncolytics Biotech Inc.
BEARISH -100
HBPCF $60M
Helix BioPharma Corp.
BEARISH -100
PRRUF $40M
Immutep Ltd
BEARISH -100
MGX $40M
Metagenomi, Inc. Common Stock
BEARISH -100
KYNB $30M
Kyntra Bio, Inc.
BEARISH -100
MCRB $30M
Seres Therapeutics, Inc.
BEARISH -100
ATYR $30M
aTyr Pharma, Inc.
BEARISH -100
IMMP $30M
Immutep Limited
BEARISH -100
BCDA $20M
BioCardia, Inc.
BEARISH -100
ACXP $10M
Acurx Pharmaceuticals, Inc.
BEARISH -100
RDTCF $10M
Rapid Dose Therapeutics Corp.
BEARISH -100
HMTXF $10M
Hemostemix Inc
BEARISH -100
LTRN $10M
Lantern Pharma Inc.
BEARISH -100
OTLC $10M
Oncotelic Therapeutics, Inc.
BEARISH -100
PASG $10M
Passage Bio, Inc.
BEARISH -100
PRVCF $10M
PreveCeutical Medical Inc.
BEARISH -100
MSLE $10M
Satellos Bioscience Inc.
BEARISH -100
CLRB $10M
Cellectar Biosciences, Inc.
BEARISH -100
PHIO $10M
Phio Pharmaceuticals Corp.
BEARISH -100
TVRD $10M
Tvardi Therapeutics, Inc.
BEARISH -100
JSPR $10M
Jasper Therapeutics, Inc.
BEARISH -100
LABT —
Lakewood-Amedex Biotherapeutics, Inc.
BEARISH -100
PBIGF —
Paradigm Biopharmaceuticals Limited
BEARISH -100
MBIO —
Mustang Bio, Inc.
BEARISH -100
GOVX —
GeoVax Labs, Inc.
BEARISH -100
BRTX —
BioRestorative Therapies, Inc.
BEARISH -100
BLEG —
Branded Legacy, Inc.
BEARISH -100
AGNPF —
Grey Matters Health Inc.
BEARISH -100
YECO —
EV Biologics, Inc.
BEARISH -100
ERNA —
Ernexa Therapeutics Inc.
BEARISH -100
AXIM —
AXIM Biotechnologies, Inc.
BEARISH -100
PKTX —
ProtoKinetix, Incorporated
BEARISH -100
ZVSA —
ZyVersa Therapeutics, Inc.
BEARISH -100
SCPS —
Scopus BioPharma Inc.
BEARISH -100
REVB —
Revelation Biosciences, Inc.
BEARISH -100
CYYNF —
Cynata Therapeutics Limited
BEARISH -100
XAGE —
Longevity Health Holdings Inc.
BEARISH -100
CRIS —
Curis, Inc.
BEARISH -100
MBRX —
Moleculin Biotech, Inc.
BEARISH -100
AZTR —
Azitra, Inc.
BEARISH -100
GBLX —
GB Sciences, Inc.
BEARISH -100
CLAZF —
Claritas Pharmaceuticals, Inc.
BEARISH -100
BXRXQ —
Baudax Bio, Inc.
BEARISH -100

Peer Comparison

Symbol Mkt Cap P/E ROE % ROIC % Net Mgn % Rev Grw % Piotroski Signal 1Y Ret %
BCLI Brainstorm Cell Therapeutics Inc. $10M -1.0 119.2 76.7 — -100.0 1 NEUTRAL 31.0
ABSI Absci Corporation $1.9B -13.8 -57.7 -213.1 -10443.4 -62.3 5 BULLISH 253.7
PMVP PMV Pharmaceuticals, Inc. $100M -1.3 -70.9 815.8 — — 2 BULLISH 31.6
ICU SeaStar Medical Holding Corporation $10M -1.2 -356.9 415.0 -606.5 123.6 4 BULLISH -24.8
FTRE Fortrea Holdings Inc. $1.9B -21.5 -15.3 0.6 -1.9 -2.1 6 BULLISH 110.1
NVAX Novavax, Inc. $1.7B -6.9 323.7 29.2 -94.2 -61.6 2 BULLISH 10.1
SEER Seer, Inc. $120M -1.8 -26.4 -58.8 -544.8 -13.3 3 BULLISH 2.3
NAUT Nautilus Biotechnolgy, Inc. $250M -4.4 -36.2 -66.2 -7615.3 — 3 BULLISH 134.7
TLSA Tiziana Life Sciences Ltd $70M -4.1 -1250.8 978.2 — — 1 BULLISH -42.6
AGEN Agenus Inc. $350M 3.1 -33.2 -20.4 -1.6 30.5 6 BULLISH 114.4
DNA Ginkgo Bioworks Holdings, Inc. $810M -2.5 -56.3 -44.0 -231.7 -51.5 2 BULLISH -15.9
YDES YD Bio Limited Ordinary Shares $570M — — — — — — BULLISH -54.7
DMAC DiaMedica Therapeutics Inc. $440M -11.4 -114.6 616.3 — — 2 BULLISH 20.0
SRZN Surrozen, Inc. $220M -0.7 387.2 11.1 1003.5 -8.8 2 BULLISH 114.6
MREO Mereo BioPharma Group plc $60M -2.1 -67.8 6194.3 — -100.0 2 BULLISH -81.5
CVM CEL-SCI Corporation $20M -0.9 -252.5 -142.9 — -100.0 4 BULLISH -76.8
SXTP 60 Degrees Pharmaceuticals, Inc. — -0.2 -321.8 -390.2 -1089.2 68.0 3 BULLISH -5.4
SPHRF Starpharma Holdings Limited $240M -46.8 -83.3 -941.6 -725.1 50.8 5 BULLISH 480.0
INKT MiNK Therapeutics, Inc. $60M -5.2 57.9 42.8 — — 3 BULLISH -14.1
CRVO CervoMed Inc. $30M -0.9 -107.6 1244.8 — — 2 BULLISH -62.4
YDESW YD Bio Limited Warrants — — — — — — — BULLISH -60.5
BCTXZ BriaCell Therapeutics Corp. Warrant — -0.3 -168.1 -2016.9 — — 1 BULLISH 39.8
MBXBF Microbix Biosystems Inc. $30M -8.5 -16.4 -14.6 -19.9 -27.1 3 BULLISH 18.5
ZIVO ZIVO Bioscience, Inc. $20M -2.9 185.9 147.5 — -62.5 2 BULLISH -67.5
SLGL Sol-Gel Technologies Ltd. $240M -12.8 -35.9 -228.0 36.4 282.9 3 BULLISH 144.1
BYSI BeyondSpring Inc. $30M -4.8 20.3 15.7 — 100.0 2 BULLISH -56.0
PULM Pulmatrix, Inc. $10M -1.4 -98.3 -835.1 — -100.0 3 BULLISH -68.0
DRTSW Alpha Tau Medical Ltd. $1.6B -14.2 -141.7 -17.1 — — 3 BULLISH 1253.3
TTRX Turn Therapeutics Inc. $400M -45.7 -952.4 115.0 — — 2 BULLISH —
OBIO Orchestra BioMed Holdings, Inc. $360M -6.0 -397.3 468.3 -26994.3 986.1 4 BULLISH 133.3
NTRB Nutriband Inc. $90M -12.7 -100.7 -264.9 -201.3 -37.3 3 BULLISH 0.1
ATGGF Actinogen Medical Limited $220M -11.2 -146.7 -361.2 — -63.0 1 BULLISH 140.0
DMTRF 3-D Matrix, Ltd. $350M 13.8 92.3 29.3 50.9 56.9 5 BULLISH 80.0
LITS Lite Strategy, Inc. $50M -0.2 -170.9 -28.2 — — 2 BULLISH -46.1
GRDX GridAI Technologies Corp. $30M -0.9 -55.6 -51.7 -14927.4 67.4 2 BULLISH -11.2
LKFT Lakefront Biotherapeutics N.V. $1.9B — — — — — — BULLISH —
XERS Xeris Biopharma Holdings, Inc. $1.6B -93.5 118.2 18.3 -33.8 36.3 6 BULLISH 13.4
RIGL Rigel Pharmaceuticals, Inc. $870M 2.7 126.9 88.5 22.0 3.3 4 BULLISH 67.4
GYRE Gyre Therapeutics, Inc. $790M -35.7 -15.6 -22.3 -36.4 16.8 3 BULLISH -6.2
ENGN enGene Holdings Inc. $130M -6.9 -2.3 134.1 — -100.0 2 BULLISH -74.5
NRXS NeurAxis, Inc. $90M -9.2 -143.2 464.1 -118.1 65.2 6 BULLISH 128.6
RLYB Rallybio Corporation $90M 2.2 64.9 -1399.7 — -15.1 6 BULLISH 3191.6
ABPO Abpro Holdings, Inc. — — — — — — — BULLISH —
NMAD NOMAD Power Solutions, Inc. $50M — — — — — — BULLISH —
PPTDF PeptiDream Inc. $940M -38.3 -7.1 -9.6 -25.7 47.8 4 BULLISH -34.3
CELU Celularity Inc. $50M -0.6 349.7 -195.2 17.6 -62.8 2 BULLISH -21.6
ANTX AN2 Therapeutics, Inc. $210M -5.3 -50.1 1243.3 — — 2 BULLISH 342.6
CASBF CanSino Biologics Inc. $1.6B 523.4 0.8 -1.2 11.0 32.5 7 BULLISH -29.6
FLNA Filana Therapeutics, Inc. $40M -1.1 -13.5 38.9 — — 2 BULLISH —
HRGN Harvard Apparatus Regenerative Technology Inc. $40M -5.5 239.0 256.6 -409.4 — 2 BULLISH —
INAB IN8bio, Inc. $10M -0.7 -111.1 -576.1 — — 4 BULLISH -39.4
VCNX Vaccinex, Inc. — -0.5 776.6 414.6 -1584.0 226.6 3 BULLISH 62.9
HEPA Hepion Pharmaceuticals, Inc. — -0.3 -125.6 710.2 — — 3 BULLISH 76.1
PDSB PDS Biotechnology Corporation $40M -1.2 -544.0 456.9 — — 1 BULLISH -26.6
BCTX BriaCell Therapeutics Corp. $40M -0.3 -179.9 -2435.2 — — 2 BULLISH -67.9
KROS Keros Therapeutics, Inc. $230M -3.1 -17.2 -392.2 — -93.6 3 BULLISH -25.6
EVAX Evaxion Biotech A/S $20M -0.5 -109.8 -260.4 — 135.9 6 BULLISH -27.9
BMNDF Biomind Labs Inc. $40M -24.5 85.8 101.7 — — 2 BULLISH 2811.4
DRTS Alpha Tau Medical Ltd $1.3B -14.2 -141.7 -17.1 — — 3 BULLISH 238.0
BITRF Biotron Limited $20M -3.6 -137.4 -107.4 -113.4 -24.0 3 BULLISH 219.2
QPTFF Quest PharmaTech Inc. $10M 1.6 3.9 -1.7 — — 4 BULLISH 125.6
CURX Curanex Pharmaceuticals Inc Common Stock $10M -0.6 -218.7 -392.2 — — 1 BULLISH -69.5
ADAPY Adaptimmune Therapeutics plc $10M -0.1 -1341.1 268.4 -221.8 -54.0 0 BULLISH -69.5
NKGN NKGen Biotech, Inc. — -0.0 150.9 — -4511.3 — 3 BULLISH -90.0
TRVN Trevena, Inc. — -0.0 344.3 -3198.4 -1745.2 -82.9 3 BULLISH 0.0
HALB Halberd Corporation — -31.8 11.6 12.4 — -52.1 1 BULLISH -13.0
STTK Shattuck Labs, Inc. $610M -13.2 -39.2 -29.3 — -66.6 4 BULLISH 182.8
ACIU AC Immune S.A. $280M -5.2 -78.5 96.7 12.4 -39.5 2 BULLISH -10.2
LIANY LianMedical $10M 1.3 74.7 -612.1 — — 6 BULLISH 7.9
ANIX Anixa Biosciences, Inc. $100M -9.7 -67.1 -1110.2 — — 3 BULLISH -13.0
TXTM ProText Mobility, Inc. $10M 58.0 -0.4 -0.3 — -100.0 1 BULLISH 87.1
PBM Psyence Biomedical Ltd. — — — — — — — BULLISH 75.1
NTLA Intellia Therapeutics, Inc. $1.7B -3.6 -55.4 -92.1 -1392.3 12.6 4 LEAN BULL -34.6
ENTA Enanta Pharmaceuticals, Inc. $380M -5.4 -70.1 141.5 -135.8 0.7 4 LEAN BULL 22.1
PLX Protalix BioTherapeutics, Inc. $220M 11.2 31.2 47.1 19.0 30.1 5 LEAN BULL 14.8
CBUS Cibus, Inc. $130M -1.0 -225.9 -157.2 -2227.9 -10.3 2 LEAN BULL 27.6
HOWL Werewolf Therapeutics, Inc. $50M -1.3 -119.9 354.7 17.5 — 4 LEAN BULL -52.4
ACOG Alpha Cognition Inc $140M -8.3 -55.3 -198.4 -144.3 232.7 2 LEAN BULL 14.8
ZHCLF Zenith Capital Corp. $20M -0.0 35107.2 37766.2 -360.0 — 3 LEAN BULL 42.9
GLWLF Glow Lifetech Corp. $10M -50.0 -11.1 -21.1 -26.6 59.2 5 LEAN BULL -5.3
VIR Vir Biotechnology, Inc. $1.9B -6.0 -26.1 -38.9 33.5 1495.9 4 LEAN BULL 96.0
NYMXF Nymox Pharmaceutical Corporation — -0.7 193.9 89.4 — — 2 LEAN BULL -44.4
NNVC NanoViricides, Inc. $30M -3.1 -189.3 -0.0 — — 2 LEAN BULL -11.1
PHRRF PharmaTher Holdings Ltd. — -8.3 -125.3 309.7 — — 2 LEAN BULL -71.8
KRSA Korsana Biosciences, Inc. $140M — — — — — — LEAN BULL —
MNKD MannKind Corporation $1.2B -27.2 71.4 4.0 -17.4 30.5 2 LEAN BULL -29.4
ATNM Actinium Pharmaceuticals, Inc. $40M 3.2 45.9 -197.8 79.7 — 3 LEAN BULL -26.9
VTGN VistaGen Therapeutics, Inc. $10M -0.2 -131.6 644.6 -3499.8 161.3 2 LEAN BULL -92.1
TRAW Traws Pharma, Inc. $10M -1.1 35.4 225.5 — 606.3 3 LEAN BULL -69.9
ASBP Aspire Biopharma Holdings, Inc. — -1.1 -1032.1 1368.4 -2009.6 — 6 LEAN BULL -96.6
NMTRQ 9 Meters Biopharma, Inc. — — — — — — — LEAN BULL 0.0
HYFT MindWalk Holdings Corp. $60M -5.2 -78.4 -298.7 -93.9 -16.9 5 LEAN BULL -24.7
VERU Veru Inc. $40M -4.2 -62.3 -211.2 — -100.0 3 LEAN BULL -35.5
CNSP CNS Pharmaceuticals, Inc. $10M -0.2 -106.6 748.6 — — 3 LEAN BULL -38.9
CUBT Curative Biotechnology, Inc. $10M -2.3 31.0 15.3 — — 4 LEAN BULL -27.4
APUS Apimeds Pharmaceuticals US, Inc — -0.1 -100.1 -12.6 — — 2 LEAN BULL -81.2
GNLX Genelux Corporation $110M -2.9 -168.9 20537.7 — — 2 LEAN BULL -41.8
HSTC HST Global, Inc. $100M -27.8 -5.0 -2.1 2.7 — 3 LEAN BULL 349900.0
RNTX Rein Therapeutics Inc. $20M -0.4 -753.6 53.9 — — 3 LEAN BULL -32.1
BRAXF Braxia Scientific Corp. — -0.1 -254.6 -2393.3 -184.2 27.6 3 LEAN BULL -92.2
BIXT Bioxytran, Inc. — -0.7 92.2 68.7 — — 4 LEAN BULL -66.3
NMLSF Restart Life Sciences Corp. — -1.8 -214.3 -153.9 -307.0 — 2 LEAN BULL 83.8
HRTX Heron Therapeutics, Inc. $70M -1.9 334.6 -7.6 -14.6 1.0 3 LEAN BULL -72.2
MAZE Maze Therapeutics, Inc. $1.5B -9.6 -37.3 -112.3 — — 3 NEUTRAL 2.4
SPRO Spero Therapeutics, Inc. $70M 8.5 19.2 -128.5 — -7.0 7 NEUTRAL -39.3
AEON AEON Biopharma, Inc. $10M -0.1 350.0 98.0 — — 2 NEUTRAL -67.1
ORGS Orgenesis Inc. $10M -0.3 764.3 1083.0 2628.2 -192.0 1 NEUTRAL -26.6
CPMV Mosaic ImmunoEngineering Inc. — -1.2 9.2 7.5 — — 2 NEUTRAL -84.9
CAPR Capricor Therapeutics, Inc. $510M -3.7 -73.7 -107.5 — -100.0 3 NEUTRAL 14.4
PBYI Puma Biotechnology, Inc. $480M 17.7 22.0 52.8 14.5 -2.9 6 NEUTRAL 80.5
DARE Dare Bioscience, Inc. $10M -1.1 165.3 136.8 -1590.4 7816.7 3 NEUTRAL -60.8
KPRX Kiora Pharmaceuticals, Inc. $10M -1.0 -56.4 -2884.1 — — 2 NEUTRAL -9.5
COYA Coya Therapeutics, Inc. $110M -4.5 -0.1 -18.8 -2723.4 1793.8 3 NEUTRAL -17.8
AFMDQ Affimed N.V. — — — — — — — NEUTRAL —
ANL Adlai Nortye Ltd. $800M -7.7 -22.4 -317.5 -36.3 223.4 4 NEUTRAL 738.3
CDIO Cardio Diagnostics Holdings, Inc. $10M -0.7 -75.4 -230.9 -28012.5 -25.9 3 NEUTRAL -54.0
CLGN CollPlant Biotechnologies Ltd. — -0.4 -162.0 -369.3 -2524.1 -86.8 2 NEUTRAL -86.5
OMER Omeros Corporation $1.4B 9.7 -89.2 71.8 46.4 — 5 NEUTRAL 349.5
SOLTF Nxera Pharma Co., Ltd. $720M -14.1 -12.0 -1.7 -2.6 7.5 4 NEUTRAL 22.2
MLLCF Molecular Partners AG $150M -2.4 -62.1 650.3 — -100.0 2 NEUTRAL 14.6
PRNAF Alterity Therapeutics Limited $90M -3.4 -117.0 -556.9 — -41.1 4 NEUTRAL 13233.3
OKYO OKYO Pharma Limited $60M -6.1 -213.7 128.1 — — 3 NEUTRAL -26.9
CLNN Clene Inc. $50M -1.1 237.2 132.5 -14915.6 -31.1 2 NEUTRAL -40.5
KNTPF Kintor Pharmaceutical Limited $110M -3.7 -111.3 -105.7 -145.6 3136.1 3 NEUTRAL -6.7
BXPHF Botanix Pharmaceuticals Limited $40M -0.6 -181.3 -285.1 -203.1 1249.3 2 NEUTRAL -88.1
MMIRF MedMira Inc. $30M -13.6 11.8 21.7 -200.5 45.7 4 NEUTRAL -55.8
ENVB Enveric Biosciences, Inc. $10M -0.1 -170.0 3225.6 — — 4 NEUTRAL -81.4
GRI GRI Bio, Inc. — -0.0 -142.0 1227.5 — — 5 NEUTRAL -96.5
HLSQ Tessera Defense and Homeland Security Inc — — — — — — — N/A —
QNTM Quantum BioPharma Ltd. $20M -0.6 -425.3 175.1 — — 4 NEUTRAL -79.1
SIGY Sigyn Therapeutics, Inc. — -0.0 61.7 32.8 — -100.0 1 NEUTRAL -99.1
PHMMF Pharma Mar, S.A. $1.6B 21.9 24.9 35.9 -2.0 15.5 7 NEUTRAL -7.5
INRLF Valneva SE $640M -2.8 -118.0 -54.8 -89.3 -27.2 1 NEUTRAL -31.5
XLO Xilio Therapeutics, Inc. $60M -6.0 -55.0 43.1 -34.1 327.3 6 NEUTRAL 982.1
CNTN Canton Strategic Holdings Inc $170M -1.4 -14.6 -7.2 -1287.2 — 2 NEUTRAL —
CBDG THC Farmaceuticals, Inc. — -41.9 2.0 -0.9 — 28.1 5 NEUTRAL 83.2
LIMNW Liminatus Pharma, Inc. Warrants — -0.2 -4165.9 252.1 — — 2 NEUTRAL -85.8
RBSH Rebus Holdings, Inc. — -0.0 -9.7 8.9 — — 2 NEUTRAL 0.0
VRCI Verde Science, Inc. — -0.0 72.3 23.0 — — 5 NEUTRAL 1900.0
HAVLF HAVN Life Sciences Inc. — -0.0 -275.3 -163.4 5734.1 876.8 3 NEUTRAL 0.0
VSTM Verastem, Inc. $680M -3.1 -471.2 6197.3 -86.5 3995.7 4 NEUTRAL -12.5
INTI Inhibitor Therapeutics, Inc. $20M -5.1 358.8 88.0 — — 1 NEUTRAL 96.0
LIMN Liminatus Pharma, Inc. Class A Common Stock $10M -0.2 294.4 252.1 — — 4 NEUTRAL -95.5
VBIO Valion Bio, Inc. $10M -0.0 -122.7 -45.5 — — 2 NEUTRAL —
MTNB Matinas BioPharma Holdings, Inc. — -0.1 -154.3 -504.1 — — 4 NEUTRAL -90.6
RARE Ultragenyx Pharmaceutical Inc. $1.5B -2.6 839.4 -67.5 -43.0 17.5 2 NEUTRAL -49.2
TENX Tenax Therapeutics, Inc. $50M -1.3 -59.8 1235.8 — — 1 NEUTRAL -74.0
VRPX Virpax Pharmaceuticals, Inc. — -0.0 2.6 0.4 — — 1 NEUTRAL -55.6
RGIN Regenicin, Inc. — -0.0 16.9 4.1 — — 4 NEUTRAL 0.0
ONCO Onconetix, Inc. — -0.1 -105.2 -83.7 -16748.3 -51.3 3 NEUTRAL -75.7
SRNE Sorrento Therapeutics, Inc. — -0.0 1502.8 468.4 -633.7 16.9 2 NEUTRAL -77.1
GLSI Greenwich LifeSciences, Inc. $250M -11.0 -951.6 299.9 — — 2 LEAN BEAR 68.0
MDWD MediWound Ltd. $170M -8.4 -72.4 -255.1 -239.1 -40.3 2 LEAN BEAR -22.7
ACRV Acrivon Therapeutics, Inc. Common Stock $90M -1.1 -64.6 5251.5 — — 1 LEAN BEAR 9.9
AURX Nuo Therapeutics, Inc. $60M -29.9 170.6 280.3 -15.7 166.6 3 LEAN BEAR -35.9
SGMOQ Sangamo Therapeutics, Inc. $60M — — — — — — LEAN BEAR —
GWIN Glorywin Entertainment Group, Inc. $230M -26081.4 11.7 5.1 — — 1 LEAN BEAR 254.3
CLYYF Celyad Oncology S.A. $10M 2.7 -114.9 -1433.2 64360.6 102.9 4 LEAN BEAR -31.7
PBLA Panbela Therapeutics, Inc. — -0.0 270.3 240.0 — 100.0 3 LEAN BEAR -77.8
MNOV MediciNova, Inc. $90M -8.2 -25.6 -78.2 -504.8 583.9 3 LEAN BEAR 42.4
PTIX Protagenic Therapeutics, Inc. — 0.3 -485.4 -367.8 — 100.0 6 LEAN BEAR -77.1
KLDO Kaleido Biosciences, Inc. — -0.0 -591.2 1121.9 -4292.5 13.2 2 LEAN BEAR 0.0
MENS Jyong Biotech Ltd. Ordinary Shares $170M — — — — — — LEAN BEAR -95.5
NVCT Nuvectis Pharma, Inc. $580M -16.7 -214.6 174.4 — — 1 LEAN BEAR 261.7
INDP Indaptus Therapeutics, Inc. $270M -0.3 -318.0 6437.4 — — 4 LEAN BEAR -32.0
GLSHQ Gelesis Holdings, Inc. — -0.0 391.0 -233.6 -693.9 -45.8 3 LEAN BEAR 0.0
WINT Windtree Therapeutics, Inc. — -0.0 1111.0 -2375.5 — — 3 LEAN BEAR -99.6
VINC Vincerx Pharma, Inc. — -0.0 -3136.4 910.2 — -18.7 5 LEAN BEAR -72.2
XNCR Xencor, Inc. $1.8B -11.4 -29.1 -152.4 -42.4 -36.1 2 LEAN BEAR 110.0
PROK ProKidney Corp. $580M -3.0 9.2 13.2 -18948.0 55.2 1 LEAN BEAR -33.9
KTTA Pasithea Therapeutics Corp. $20M -0.2 -65.5 0.0 — — 4 LEAN BEAR -35.8
CELZ Creative Medical Technology Holdings, Inc. — -0.5 -78.0 8335.2 — -50.0 2 LEAN BEAR -71.7
MDXG MiMedx Group, Inc. $670M 114.8 2.9 5.8 -23.1 -2.4 6 LEAN BEAR -32.8
XRTX XORTX Therapeutics Inc. — -0.3 -99.1 -68.5 — — 3 LEAN BEAR 108.3
DCOY Decoy Therapeutics Inc. — — — — — — — LEAN BEAR —
FPMI FluoroPharma Medical, Inc. — -0.0 22.7 39.7 — — 2 LEAN BEAR 100.0
TLOG TetraLogic Pharmaceuticals Corporation — -0.0 382.3 479.8 — — 1 LEAN BEAR -50.0
CSPHF CStone Pharmaceuticals $1.2B -17.9 -74.4 -553.0 -123.0 -36.4 4 LEAN BEAR -24.5
LYRA Lyra Therapeutics, Inc. — -0.0 -6595.0 -671.6 -99300.0 -74.1 4 LEAN BEAR -98.4
BDRX Biodexa Pharmaceuticals Plc — -0.0 -116.7 -229.9 — -100.0 4 LEAN BEAR -98.1
GNFTF Genfit S.a. $790M -4.5 -575.3 -453.0 -124.0 1.4 4 LEAN BEAR 323.4
ATOS Atossa Therapeutics, Inc. $20M -0.5 -89.2 -4213.1 — — 2 LEAN BEAR -83.0
JAGX Jaguar Health, Inc. — -0.0 -501.9 -118.9 -1035.3 135.5 4 LEAN BEAR -99.7
GBIM GlobeImmune, Inc. — -0.0 -66.2 25.0 -91.5 55.1 4 LEAN BEAR 0.0
AMBS Amarantus BioScience Holdings, Inc. — -0.0 7.3 3.8 -4080.5 — 3 LEAN BEAR -66.7
PBMWW Psyence Biomedical Ltd. Warrant — — — — — — — LEAN BEAR -29.7
RVLPQ RVL Pharmaceuticals plc — -0.0 -182.4 -101.1 -289.3 5.6 3 LEAN BEAR 0.0
GSTC GlobeStar Therapeutics Corporation — -0.0 60.9 49.1 — — 4 LEAN BEAR 0.0
DNAG DNAPrint Genomics, Inc. — -0.0 63.1 -156.0 -826.7 -15.2 3 LEAN BEAR 100.0
ATRA Atara Biotherapeutics, Inc. $90M -8.0 46.3 30.3 -767.3 -96.7 2 LEAN BEAR -34.4
XBIT XBiotech Inc. $70M -1.5 -29.9 -201.2 — — 2 LEAN BEAR -17.1
VTIAF FamiCord AG $50M -7.1 -84.3 -13.6 -5.1 0.1 5 LEAN BEAR 16.0
ALGS Aligos Therapeutics, Inc. $30M -0.8 -113.6 -1246.4 -5.4 893.0 2 LEAN BEAR -46.2
BPTH Bio-Path Holdings, Inc. — -0.0 49.0 15.2 — -100.0 1 LEAN BEAR -99.6
CMRA Comera Life Sciences Holdings, Inc. — -0.0 235.6 124.2 -1580.0 81.8 4 LEAN BEAR 0.0
SRBCF Sirona Biochem Corp. — -0.7 111.4 1025.7 -34808.5 -119.4 2 LEAN BEAR -57.9
TBPH Theravance Biopharma Inc $880M 16.0 20.9 -7.2 -28.5 35.1 7 LEAN BEAR 21.2
EQ Equillium, Inc. $90M -5.5 -59.0 2703.6 — -100.0 3 LEAN BEAR -4.7
PTN Palatin Technologies, Inc. $20M -1.8 -877.5 1176.9 -1449.1 — 5 LEAN BEAR 18.9
BOLT Bolt Biotherapeutics, Inc. $10M -0.2 -111.6 -138.8 -154400.0 12.8 3 LEAN BEAR -39.0
SKYE Skye Bioscience, Inc. $10M -0.2 -233.9 389.5 — — 3 LEAN BEAR -60.6
LSTA Lisata Therapeutics, Inc. $10M -0.9 -99.9 590.1 — -90.7 2 LEAN BEAR -40.0
PYPD PolyPid Ltd. $100M -3.5 -1913.8 231.6 — — 3 LEAN BEAR 54.0
PARD Poniard Pharmaceuticals, Inc. — -0.0 -210.4 -442.5 — — 3 LEAN BEAR 0.0
TVGN Tevogen Bio Holdings Inc. $30M -1.2 235.3 244.1 — — 5 LEAN BEAR 710.5
ALZN Alzamend Neuro Inc $10M -0.6 -373.2 -30751.3 — — 1 LEAN BEAR -44.1
BPMUF Basilea Pharmaceutica AG $940M 15.7 140.1 185.7 23.5 49.5 9 LEAN BEAR 12.6
ANNX Annexon, Inc. $690M -3.6 -105.3 -11323.3 — — 2 BEARISH 38.3
SNTI Senti Biosciences, Inc. $10M -0.2 -466.5 -430.9 -75000.0 — 2 BEARISH -77.6
CODX Co-Diagnostics, Inc. $10M -0.0 -174.8 -218.8 -3782.4 -28.1 3 BEARISH -89.8
ARTL Artelo Biosciences, Inc. — -0.0 -705.7 -1031.2 — — 5 BEARISH -91.4
OGEN Oragenics, Inc. — -0.1 -1307.1 4273.7 — — 3 BEARISH -64.8
BIOAF Bioasis Technologies Inc. — -0.1 135.1 538.8 -661.8 614.1 2 BEARISH -50.0
IPIX Innovation Pharmaceuticals Inc. — -0.0 -115.7 -377.9 — -133.3 3 BEARISH -93.3
SLXN Silexion Therapeutics Ltd. — -0.0 -17022.0 -931.4 — — 3 BEARISH -93.1
CSBR Champions Oncology, Inc. $70M -62.5 -30.5 -25.2 -5.3 4.4 4 BEARISH -22.8
ELUT Elutia Inc $30M 0.6 -397.0 -290.2 -315.0 -48.8 6 BEARISH -12.0
LONA LeonaBio, Inc. $20M — — — — — — BEARISH —
APVO Aptevo Therapeutics Inc. — -0.0 -420.3 -4688.7 — — 1 BEARISH -92.9
NNLX NanoLogix, Inc. — — — — — — — BEARISH -20.0
MCET MultiCell Technologies, Inc. — -0.1 101.2 99.1 -81.8 1532.7 5 BEARISH 0.0
SNBIF SanBio Company Limited $1.3B -19.7 -50.0 1250.3 — — 4 BEARISH 0.0
REPL Replimune Group, Inc. $1.1B -4.1 -107.9 -2853.5 — — 1 BEARISH 210.4
GALT Galectin Therapeutics Inc. $260M -9.1 21.9 99.4 — — 2 BEARISH -6.7
SCNLF Scancell Holdings plc $150M -17.9 254.8 3518.0 — -10.6 1 BEARISH 5.9
RANI Rani Therapeutics Holdings, Inc. $50M -3.0 -179.1 245.5 -432.7 306.4 5 BEARISH 59.3
REPCF RepliCel Life Sciences Inc. — -9.4 -248.8 -13.9 -80.9 200.0 6 BEARISH 0.0
PROT Proteonomix, Inc. — -0.0 77.5 -1239.4 — -63.1 4 BEARISH 0.0
JUNS Jupiter Neurosciences, Inc. — -0.1 -1888.7 5586.0 -9380.9 — 3 BEARISH -98.0
FATE Fate Therapeutics, Inc. $270M -2.2 -60.7 -140.1 -1448.6 -23.4 2 BEARISH 109.0
ALEC Alector, Inc. $200M -1.6 -385.1 66.8 -692.5 -82.9 1 BEARISH -39.7
TELO Telomir Pharmaceuticals, Inc. Common Stock $80M -0.8 -213.1 3515.1 — — 4 BEARISH -15.1
ELOX Eloxx Pharmaceuticals, Inc. $50M -10.2 -107.5 81.5 — — 4 BEARISH 15509900.5
ABVC ABVC BioPharma, Inc. $30M -3.4 -82.2 -43.0 — -100.0 2 BEARISH -66.2
NRXBF NurExone Biologic Inc. $30M — — — — — — BEARISH —
EMMA Emmaus Life Sciences, Inc. — -0.4 9.9 -9.3 21.2 11.0 4 BEARISH 423.8
CTNM Contineum Therapeutics, Inc. $490M -7.6 -28.0 -541.6 — — 4 BEARISH 19.2
ANVS Annovis Bio, Inc. $50M -0.7 -703.7 170.2 — — 1 BEARISH -44.6
MDCLF MedinCell S.A. $1.2B -24.4 264.0 116.8 -152.1 129.2 6 BEARISH 392.7
PLYX Polaryx Therapeutics, Inc. Common Stock $100M -17.1 -35.9 437.3 — — 2 BEARISH —
POLBF Poolbeg Pharma PLC $70M -9.2 -117.0 -516.5 — — 1 BEARISH 125.4
BTAIQ BioXcel Therapeutics, Inc. — — — — — — — BEARISH —
RVPH Reviva Pharmaceuticals Holdings, Inc. $10M -0.1 -32.2 45.6 — — 4 BEARISH 38.5
RCAR RenovaCare, Inc. — -0.0 -436.6 812.3 — — 2 BEARISH 0.0
ARDS Aridis Pharmaceuticals, Inc. — -0.0 4.8 10.0 -19.9 2227.6 4 BEARISH -92.3
NNBP Nanobac Pharmaceuticals, Incorporated — 0.0 358.0 221.2 -26718.6 -92.2 3 BEARISH 0.0
EHOS Ehouse Global, Inc. — -0.0 161.0 52.5 — — 1 BEARISH 900.0
IMVIF IMV Inc. — -0.2 -503.3 -2870.5 — — 1 BEARISH 1900.0
SNANF Sona Nanotech Inc. $30M -15.4 526.4 236.5 — — 1 BEARISH -47.3
AIMD Ainos, Inc. $10M -0.5 -196.3 -69.4 -3022849.3 -87.7 1 BEARISH -61.2
CNBX CNBX Pharmaceuticals Inc. — -0.5 17.8 13.3 — 100.0 3 BEARISH -71.4
AFFY Affymax, Inc. — -0.0 98.1 -302.0 17164.3 -99.9 5 BEARISH 77.8
CARM Carisma Therapeutics, Inc. — 0.0 -134.1 -376.4 98.8 159.7 3 BEARISH -99.8
NURPF Neuren Pharmaceuticals Limited $1.8B 128.1 61.3 282.5 14.6 7.2 5 BEARISH 19.0
AVBP ArriVent BioPharma, Inc. $1.3B -7.7 -53.1 2345.1 — — 3 BEARISH 53.1
SLNCF Silence Therapeutics plc $570M -2.8 -90.4 137.0 — -97.6 1 BEARISH 175.9
AVIR Atea Pharmaceuticals, Inc. $410M -2.5 -58.1 974.6 — — 3 BEARISH 78.1
WHWK Whitehawk Therapeutics Inc $210M -3.3 -45.0 963.4 — -100.0 1 BEARISH 93.7
VTVT vTv Therapeutics Inc. $80M -277.9 -11.7 91.2 — 216600.0 4 BEARISH 27.4
CNTB Connect Biopharma Holdings Limited $60M -1.1 -128.0 1785.6 -1249.0 -79.7 2 BEARISH -38.2
FNCHQ Finch Therapeutics Group, Inc. $20M — — — — — — BEARISH —
IMUC EOM Pharmaceuticals Holdings, Inc. $20M -10.5 64.4 131.0 — — 4 BEARISH 269.5
SCNI Scinai Immunotherapeutics Ltd. — -0.0 -19.2 -53.3 -435.4 162.7 2 BEARISH -4.3
ATXI Avenue Therapeutics, Inc. — -0.5 -120.0 178.4 — -100.0 2 BEARISH -43.4
MLECW Moolec Science S.A. — -0.0 -174.7 -31.5 -91.8 170.4 3 BEARISH 10.8
ORIC ORIC Pharmaceuticals, Inc. $1.3B -9.0 -39.8 -102.9 — — 3 BEARISH 4.3
IVVD Invivyd, Inc. $240M -2.1 -95.9 -302.5 -310.8 26.3 2 BEARISH -31.8
SNNAQ Sienna Biopharmaceuticals, Inc. — -0.0 -140.9 -331.4 — — 2 BEARISH 9900.0
BTAX Biostax Corp. — -0.0 7.3 5.8 — — 2 BEARISH 100.0
ALPS Alps Group Inc $70M — — — — — — BEARISH —
ANEB Anebulo Pharmaceuticals, Inc. $10M -2.1 -69.7 650.7 — — 1 BEARISH -86.7
IRD Opus Genetics, Inc. $380M -3.6 -4796.5 59.8 -1072.6 -36.1 3 BEARISH 154.4
AOBI American Oriental Bioengineering, Inc. — -0.0 -28.2 -16.5 -118.1 -10.2 3 BEARISH 1081.8
DYAI Dyadic International, Inc. $20M -2.1 522.6 1288.0 -221.0 1.5 3 BEARISH -64.1
TOVX Theriva Biologics, Inc. $10M -0.3 -101.9 -213.5 — — 2 BEARISH -40.8
OXBOF Oxford BioDynamics Plc — -0.3 -920.3 -356.4 -649.8 131.0 4 BEARISH -85.1
PHGUF Pharming Group N.V. $780M 66.6 3.7 5.8 1.7 7.8 7 BEARISH -26.0
CDXS Codexis, Inc. $150M -4.0 -69.4 -37.8 -80.5 35.9 3 BEARISH -45.6
THER Theralink Technologies, Inc. — -0.0 6.0 -69.7 5363.6 32.8 2 BEARISH 0.0
PSYBF PsyBio Therapeutics Corp — -0.0 344.6 135.0 — — 2 BEARISH -90.0
LIFS Life Stem Genetics Inc. — -2.5 -126.7 -111.5 — — 2 BEARISH 0.0
HLUN HEALTHeUNIVERSE, Inc. — — — — — — — BEARISH 900.0
PZRXQ PhaseRx, Inc. — -0.0 -228.2 8803.4 — — 2 BEARISH 0.0
NTII Neurobiological Technologies, Inc. — 0.0 48.7 441.6 89.7 99.7 4 BEARISH 0.0
AMPE Ampio Pharmaceuticals, Inc. — -0.0 -114.0 1652.6 -838.4 — 4 BEARISH 6681.5
MRPI Mera Pharmaceuticals, Inc. — -10000.0 24.3 18.3 -159.9 4.8 5 BEARISH 0.0
MRZM Marizyme, Inc. — -0.0 117.5 -190.1 — -69.0 3 BEARISH 29900.0
ZBIO Zenas BioPharma, Inc. $1.8B -2.9 -199.0 5842.1 -11145.6 -93.3 2 BEARISH 27.9
SGP SpyGlass Pharma, Inc. Common Stock $830M — — — — — — BEARISH —
ACHV Achieve Life Sciences, Inc. $740M -4.7 -845.0 24.6 — — 2 BEARISH 133.6
ORMP Oramed Pharmaceuticals Inc. $180M 1.1 74.1 -4.3 — -100.0 4 BEARISH 76.1
ENTX Entera Bio Ltd. $140M -8.2 -138.9 314.4 — -100.0 1 BEARISH 54.6
ADCT ADC Therapeutics S.A. $140M -1.7 45.3 260.9 -86.1 2.0 2 BEARISH -72.0
OTLK Outlook Therapeutics, Inc. $110M -0.3 256.9 1372.0 -225766.7 -169.4 4 BEARISH -43.0
ICCC ImmuCell Corporation $90M 115.2 2.6 10.2 25.5 8.5 6 BEARISH 47.7
TPST Tempest Therapeutics, Inc. $10M -0.2 -931.1 -564.2 — — 1 BEARISH -92.0
MTVA MetaVia Inc. $10M -0.4 -175.7 209.3 — — 0 BEARISH -86.4
LOBEF Lobe Sciences Ltd. $10M -2.7 359.0 181.6 — — 2 BEARISH 9.5
NBIO Nascent Biotech, Inc. — -0.0 230.6 328.8 — — 5 BEARISH -97.1
HCWB HCW Biologics Inc. — -0.0 -133.5 -36.8 -3849.9 707.0 3 BEARISH -92.6
BSSP Baseline Productions, Inc. — -0.0 167.7 64.9 — — 2 BEARISH -99.0
SPRC SciSparc Ltd. — -0.0 -311.5 -90652.5 -721.8 -48.8 3 BEARISH -25.2
INFIQ Infinity Pharmaceuticals, Inc. — -0.0 109.5 60.9 -1707.7 — 2 BEARISH -98.0
EXOZ eXoZymes, Inc. $50M -4.8 -187.2 913.0 — — 2 BEARISH -58.8
NIKI Niki BioSolutions, Inc. — — — — — — — BEARISH —
VBIZF Viva Biotech Holdings $400M 15.4 9.0 8.9 8.0 -15.5 5 BEARISH -31.6
BBIXF Bonus Biogroup Ltd. $50M -17.8 3245.0 2543.1 — — 2 BEARISH -42.9
NICXF Nicox S.A. $30M -7.0 -243.6 -114.4 -302.5 — 2 BEARISH 0.0
HOPHF Hemogenyx Pharmaceuticals Plc $20M -3.6 -647.5 -822.2 — — 2 BEARISH 0.0
LVCLF Algorae Pharmaceuticals Limited $20M -4.7 -83.9 -39069.8 — 451.3 3 BEARISH 51.6
BIVI BioVie Inc. $10M -0.5 -0.0 -0.0 — — 3 BEARISH -26.6
NSHSF NanoSphere Health Sciences Inc. — -1.8 4.6 11.1 — — 1 BEARISH -50.0
CHNXF ChitogenX Inc. — -0.2 23.2 36.2 — — 2 BEARISH 48.0
FORU ForU Holdings, Inc. — -0.0 759.2 -476.4 — -100.0 2 BEARISH 100.0
XSNX NovAccess Global Inc. — -0.0 27.7 18.0 — — 3 BEARISH -33.3
AVCTF Avacta Group Plc $440M -7.9 -553.3 -1587.8 -33970.3 -65.3 2 BEARISH 25.6
HNSBF Hansa Biopharma AB $330M -4.2 159.8 1182.7 -541.7 -3.7 2 BEARISH 9.7
FBIOP Fortress Biotech, Inc. $130M 0.6 107.5 -87.8 -2.5 15.5 6 BEARISH 124.5
FHTX Foghorn Therapeutics Inc. $120M -2.0 81.9 26.3 -44.7 52.0 4 BEARISH -59.0
VICP Vicapsys Life Sciences, Inc. $20M -80.2 31.3 17.6 — — 5 BEARISH -63.3
RLFTY MindMaze Therapeutics Holding S.A. — -2.1 -66.6 -70.4 -1182.3 -71.4 3 BEARISH -94.0
ELTX Elicio Therapeutics, Inc. $40M -0.9 -774.6 2147.3 — — 4 BEARISH -82.5
SEOVF Sernova Corp. $30M -3.6 57.0 76.3 — — 3 BEARISH -34.1
USRM U.S. Stem Cell, Inc. — -0.0 20.8 23.4 -2836.8 -59.1 5 BEARISH 0.0
JANX Janux Therapeutics, Inc. $1.0B -10.3 -10.7 516.9 -214.0 7162.0 4 BEARISH -28.6
STRO Sutro Biopharma, Inc. $150M -0.9 266.8 43.6 -391.6 -56.3 4 BEARISH 70.0
IBIO iBio, Inc. $70M -3.5 -65.7 21688.6 — -75.0 4 BEARISH 37.2
TIL Instil Bio, Inc. $50M -1.6 -25.3 -69.1 — — 4 BEARISH -62.2
IGC IGC Pharma, Inc. $30M -3.3 -105.2 -118.3 -757.7 -6.7 2 BEARISH -33.2
ACTU Actuate Therapeutics Inc $20M -0.9 2457.6 541.3 — — 3 BEARISH -88.2
PVCT Provectus Biopharmaceuticals, Inc. $20M -4.8 78.1 83.4 — -100.0 5 BEARISH -38.4
TCRX TScan Therapeutics, Inc. $20M -0.4 -95.8 -159.4 -2888.6 2.2 2 BEARISH -84.7
NCNA NuCana plc $10M -0.3 -70.7 -739.9 — — 4 BEARISH -77.6
GDTC CytoMed Therapeutics Limited $10M -2.6 -90.6 -106.7 -1125.6 62.6 1 BEARISH -56.2
BVAXF BioVaxys Technology Corp. — -0.9 310.6 48.4 — — 1 BEARISH -61.2
RNUGF ReNeuron Group plc — -0.0 -153.3 532.8 -1809.6 194.9 3 BEARISH 0.0
CFRXQ ContraFect Corp. — -0.0 544.7 276.9 — — 1 BEARISH -98.0
ARNI Arno Therapeutics, Inc. — -0.0 250.7 111.6 — — 3 BEARISH 0.0
LIPO Lipella Pharmaceuticals Inc. — -0.0 -361.8 4105.8 — -64.1 1 BEARISH -99.9
PANC Panacos Pharmaceuticals, Inc. — -0.0 -168.8 -792.8 -33966.7 -45.9 1 BEARISH 0.0
CDXI Cardax, Inc. — -0.0 81.1 38.5 -1740.8 -27.3 2 BEARISH 0.0
PFND Pathfinder Cell Therapy, Inc. — -0.0 22.4 46.3 — — 2 BEARISH 0.0
PMCB PharmaCyte Biotech, Inc. — -0.2 -45.6 142.9 — — 2 BEARISH -59.2
KNBIF Kane Biotech Inc. — -2.1 439.7 -2166.6 -10238.1 -97.9 2 BEARISH -43.7
SYVC Synovics Pharmaceuticals, Inc. — — — — — — — BEARISH 0.0
ADYX Adynxx, Inc. — -0.0 1148.3 259.7 — -95.1 2 BEARISH 0.0
CASIF CASI Pharmaceuticals, Inc. — — — — — — — BEARISH —
EVGN Evogene Ltd. — -0.4 265.3 101.3 -509.5 -80.4 3 BEARISH -63.0
CBIO Crescent Biopharma, Inc. $530M -1.9 -107.7 1928.6 — — 5 BEARISH 20.3
EDIT Editas Medicine, Inc. $400M -3.5 -118.8 71.4 -153.3 20.8 4 BEARISH -26.2
MGNX MacroGenics, Inc. $230M -16.3 -32.6 33.8 59.4 2.3 2 BEARISH 110.6
VANI Vivani Medical, Inc. $110M -3.5 -220.4 -127.1 — — 4 BEARISH -14.6
ACHFF Arch Biopartners Inc. $40M -19.5 73.5 165.4 — 100.0 2 BEARISH -33.2
COCP Cocrystal Pharma, Inc. $20M -1.5 -311.7 -3697.6 -3013.3 — 2 BEARISH -8.7
IMRN Immuron Limited $10M -3.1 -74.6 -356.5 -54.4 28.7 5 BEARISH -42.9
QNCX Quince Therapeutics, Inc. $10M -0.4 -153.8 1282.0 — — 4 BEARISH 1702.5
SYBX Synlogic, Inc. $10M -20.7 -5.3 306.3 — — 2 BEARISH -33.5
PPCB Propanc Biopharma, Inc. — -0.0 -161.9 -166.7 — — 4 BEARISH -70.2
NCEL NewcelX Ltd. — 8.6 -48.0 -39.1 — — 2 BEARISH —
ISCO International Stem Cell Corporation — -4.6 30.4 -10.8 -2.7 3.4 6 BEARISH 123.1
AAGH America Great Health — 2.0 -12.2 22.4 -635.8 -5.1 4 BEARISH -66.7
RGBPP Regen BioPharma, Inc. — -0.0 20.3 12.8 -1079.8 0.0 4 BEARISH -98.3
FGHQF Frontage Holdings Corporation $350M 28.9 4.2 4.5 4.6 2.1 6 BEARISH 16.8
SGMT Sagimet Biosciences Inc. $300M -7.1 -24.4 -231.4 — — 3 BEARISH 30.9
BRIBF Brii Biosciences Limited $90M -3.1 -16.9 -94.3 — -81.5 4 BEARISH -46.0
SYGGF Synairgen plc — -0.2 -114.6 -853.1 — — 2 BEARISH -50.0
GHRS GH Research PLC $1.6B -22.9 -18.8 2015.5 — — 2 BEARISH 69.0
LXRX Lexicon Pharmaceuticals, Inc. $810M -12.1 -40.2 -99.7 -4591.8 -29.0 3 BEARISH 59.6
ACRS Aclaris Therapeutics, Inc. $610M -7.6 -59.1 -206.5 -1320.1 -51.0 3 BEARISH 134.8
XBIO Xenetic Biosciences, Inc. $10M -1.9 -47.0 523.4 -140.7 33.3 4 BEARISH -29.0
OBX Obsidian Therapeutics Inc. $10M — — — — — — BEARISH —
SYBE SYBLEU Inc — -3.1 71.5 -202.2 -685.7 — 2 BEARISH 0.0
SQZB SQZ Biotechnologies Company — -0.0 -203.4 -410.2 — -44.6 0 BEARISH -14.3
STOK Stoke Therapeutics, Inc. $1.6B -7.6 -61.1 -318.5 -660.8 -86.2 2 BEARISH 8.6
IMTX Immatics N.V. $1.0B -4.2 -47.8 -858.3 -683.4 -68.0 2 BEARISH -15.7
ODTX Odyssey Therapeutics, Inc. $1.0B — — — — — — BEARISH —
SVRA Savara Inc. $990M -8.3 -105.5 -15438.9 — — 2 BEARISH 35.9
DSGN Design Therapeutics, Inc. $770M -10.5 -34.1 1787.8 — — 1 BEARISH 81.7
RZLT Rezolute, Inc. $390M -5.3 -59.0 1060.6 — — 2 BEARISH -57.5
OCGN Ocugen, Inc. $350M -4.0 1211.7 190.2 -1671.8 -3.7 2 BEARISH -39.3
CAMP CAMP4 Therapeutics Corporation $250M -1.8 -545.9 48.4 -1884.8 40.2 2 BEARISH 35.6
RNAC Cartesian Therapeutics, Inc. $220M -1.2 241.0 37.3 — 44.0 2 BEARISH -28.1
APLMW Apollomics, Inc. $160M -3.0 -4655.8 1929.8 1188.0 — 2 BEARISH -59.6
ARMP Armata Pharmaceuticals, Inc. $130M -0.7 127.8 -54.7 2953.8 -35.1 2 BEARISH 18.9
BDTX Black Diamond Therapeutics, Inc. $110M -2.6 -37.2 -1604.9 — -100.0 1 BEARISH -49.2
GOSS Gossamer Bio, Inc. $70M -0.2 178.7 117.2 182.9 32.4 3 BEARISH -94.6
OSTX OS Therapies Incorporated $70M -1.5 1924.5 268.9 — — 1 BEARISH -18.5
INNMF Amplia Therapeutics Limited $40M -6.6 -55.4 -129.9 — -32.9 3 BEARISH -20.0
RVXCF Resverlogix Corp. $20M -1.8 11.5 25.3 — — 4 BEARISH -11.2
AIM AIM ImmunoTech Inc. $10M -0.0 -2382.3 -513.5 -14569.2 -21.5 5 BEARISH -92.8
KALA KALA BIO, Inc. $10M -0.0 -345.3 -913.5 — -100.0 4 BEARISH -99.4
HIND Vyome Holdings, Inc. $10M -0.1 -193.1 516.3 -2543.3 -98.0 4 BEARISH -65.3
MVMDF The More Life Company Corp. $10M -6.2 -190.3 2590.3 -2792.5 -82.4 1 BEARISH 177.6
TSOI Therapeutic Solutions International, Inc. — -0.1 -187.6 -130.3 -5123.0 -99.7 4 BEARISH 0.0
CANF Can-Fite BioPharma Ltd. — -0.3 -184.2 353.7 -2277.7 -40.1 2 BEARISH -82.1
MRES Institute of Biomedical Research Corp. — -4.8 301783.0 -6062.7 — — 1 BEARISH -71.8
SCPX Scorpius Holdings, Inc. — -0.0 0.0 0.0 -428.3 -75.5 0 BEARISH -90.9
GNPX Genprex, Inc. — -0.0 -203.9 3484.8 — — 4 BEARISH -98.7
STAB Statera Biopharma, Inc. — -0.0 -298.8 2085.4 -769.5 1459.1 3 BEARISH -99.0
CMND Clearmind Medicine Inc. — -0.1 -104.0 593.4 — — 2 BEARISH -99.8
APLIF Appili Therapeutics Inc — -0.1 27.5 94.3 -2486.7 159.8 2 BEARISH -50.0
HESG Health Sciences Group, Inc. — -0.0 69.4 44.6 -19219.1 101.6 3 BEARISH -90.0
CEROW CERo Therapeutics Holdings, Inc. — -0.0 101.5 60.5 — -100.0 1 BEARISH -88.0
SEPN Septerna Inc $1.7B -69.8 -6.3 -93.1 -48.7 17878.5 5 BEARISH 98.5
FDMT 4D Molecular Therapeutics, Inc. $710M -5.0 -43.3 -182.0 -1929.0 278712.1 4 BEARISH 56.6
EPRX Eupraxia Pharmaceuticals Inc. $240M -7.1 -68.6 8742.2 — — 3 BEARISH 19.3
NKTX Nkarta, Inc. $180M -1.6 -38.8 -75.4 — — 1 BEARISH 16.7
IBO Impact BioMedical Inc. $50M -4.5 10.8 -30.4 -23300.0 — 5 BEARISH -34.5
IXHL Incannex Healthcare Limited $40M -2.9 -163.9 14055.6 — 378.7 5 BEARISH -75.2
ERNAW Ernexa Therapeutics Inc. Warrants — — — — — — — BEARISH —
AMGXF AnGes, Inc. $140M -3.7 -160.6 -111.8 -531.3 -16.1 4 BEARISH 0.0
ATRX Adhera Therapeutics Inc — -0.0 18.6 6.5 — — 1 BEARISH -99.0
IMMB Immunotech Laboratories, Inc. — — — — — — — BEARISH 100.0
MYMX Mymetics Corporation — -0.0 16.6 357.9 -3012.0 -62.8 2 BEARISH 0.0
NWPHF Newron Pharmaceuticals S.p.A. $420M -6.0 83.9 -32.1 -513.4 — 1 BEARISH —
ARCT Arcturus Therapeutics Holdings Inc. $370M -3.9 -46.3 -2501.0 -803.8 -79.1 1 BEARISH -36.4
APRE Aprea Therapeutics, Inc. $10M -0.6 -47.4 378.1 — -99.8 2 BEARISH -52.4
ENSC Ensysce Biosciences, Inc. $10M -0.1 -968.3 792.9 -220.8 -77.6 3 BEARISH -83.7
SYRS Syros Pharmaceuticals, Inc. — -0.0 -777.0 960.6 — -90.5 0 BEARISH 300.0
VAXX Vaxxinity, Inc. — -0.2 -150.6 2534.7 — — 0 BEARISH -99.5
DVHGF Devonian Health Group Inc. $20M -3.8 -76.1 -75.1 -1098.1 -91.5 1 BEARISH 37.7
MDCX Medicus Pharma Ltd. Common Stock $10M -0.1 -3904.0 -693.1 — — 2 BEARISH -92.8
FAMDF Futura Medical plc — -0.3 -203.4 -1029.2 -72.8 1.5 3 BEARISH -94.4
OCEA Ocean Biomedical, Inc. — -0.0 36.5 0.3 — — 1 BEARISH -83.0
BHVN Biohaven Ltd. $1.9B -2.8 -799.5 -1083.0 — — 3 BEARISH -13.1
PVLA Palvella Therapeutics, Inc. $1.9B -27.4 -46.6 137.5 — — 3 BEARISH 109.5
TYRA Tyra Biosciences, Inc. $1.2B -8.5 -45.3 -2390.9 — — 2 BEARISH 52.2
VOR Vor Biopharma Inc. $1.0B -0.1 -73.6 22.2 — — 3 BEARISH -52.4
ABUS Arbutus Biopharma Corp $880M 5.6 89.6 86.7 -507.2 1078.8 4 BEARISH -3.0
SLBT SL Science Holding Ltd $880M — — — — — — BEARISH —
EIKN Eikon Therapeutics, Inc. Common Stock $400M — — — — — — BEARISH —
CLVLF Clinuvel Pharmaceuticals Limited $290M 11.9 29.5 262.1 41.1 13.1 6 BEARISH -28.1
UPB Upstream Bio, Inc. $270M -1.7 -46.0 -1266.4 -5136.1 49.2 3 BEARISH -70.9
TRDA Entrada Therapeutics, Inc. $210M -1.4 -54.1 -236.6 -4762.0 -94.1 1 BEARISH -8.5
ELDN Eledon Pharmaceuticals, Inc. $190M -2.5 -110.7 411.1 — — 2 BEARISH -6.4
DTIL Precision BioSciences, Inc. $170M -2.3 -135.1 203.1 — 3473.0 5 BEARISH 16.0
NRXP NRx Pharmaceuticals, Inc. $130M -3.9 131.2 61.3 -1500.5 — 5 BEARISH -12.9
HURA TuHURA Biosciences, Inc. $120M -3.5 -161.4 -137.6 — — 2 BEARISH -24.8
ADAG Adagene Inc. $110M -6.0 -72.6 324.2 -1011.1 1054.7 4 BEARISH 42.5
AARD Aardvark Therapeutics, Inc. Common Stock $110M -1.6 -66.0 -3642.4 — — 1 BEARISH -66.1
KRRO Korro Bio, Inc. $100M -1.0 -97.7 -196.6 — -62.1 2 BEARISH -78.0
RNXT RenovoRx, Inc. $70M -5.0 -125.2 4391.9 -320.2 198.5 3 BEARISH 17.9
BOLD Boundless Bio, Inc. $60M -0.9 -67.9 807.9 — — 2 BEARISH 113.0
INMB INmune Bio, Inc. $50M -2.8 -74.8 -475.4 — -100.0 2 BEARISH -9.4
NDTP NDT Pharmaceuticals Inc. $40M -50.0 -3.8 -1.5 -458.3 — 4 BEARISH -78.2
TELIF Telescope Innovations Corp. $20M -7.2 -229.2 -80.7 -116.8 66.3 2 BEARISH 13.6
NEUP Neuphoria Therapeutics Inc. $20M -0.5 -0.2 -0.2 -417.7 -91.9 4 BEARISH -75.0
KPTI Karyopharm Therapeutics Inc. $20M -0.0 79.0 36.3 -200.5 6.8 2 BEARISH -87.1
ALLR Allarity Therapeutics, Inc. $20M -1.3 -157.1 -96.5 — — 2 BEARISH -35.8
MDNAF Medicenna Therapeutics Corp. $20M — — — — — — BEARISH —
PHYOF IXICO plc $10M -3.8 -32.4 -40.1 -28.5 -1.5 2 BEARISH 0.0
CTXR Citius Pharmaceuticals, Inc. $10M -0.3 -70.3 -85.4 -593.3 4456.8 3 BEARISH -61.2
PLRZ Polyrizon Ltd. $10M -2.3 -30.9 -68.2 — — 1 BEARISH 46.9
ENGNW enGene Holdings Inc. Warrants $10M -6.9 -2.3 134.1 — -100.0 2 BEARISH -69.2
ADIL Adial Pharmaceuticals, Inc. $10M -0.2 -2011.6 159.6 — — 3 BEARISH -56.2
NRSN NeuroSense Therapeutics Ltd. $10M -0.4 779.3 571.3 — — 3 BEARISH -83.9
SNGX Soligenix, Inc. $10M -0.3 -241.7 304.6 — — 4 BEARISH -88.4
GTBP GT Biopharma, Inc. $10M -0.1 -798.9 927.8 — — 2 BEARISH -62.8
HTDS Hard to Treat Diseases Inc. — — — — — — — BEARISH -95.0
CALA Calithera Biosciences, Inc. — -0.0 -141.5 979.6 — -100.0 1 BEARISH 0.0
EVLO Evelo Biosciences, Inc. — -0.0 948.0 605.0 — — 2 BEARISH -80.0
NTRR Neutra Corp. — 1.0 1.2 -42.9 632.2 1449.2 6 BEARISH -33.3
VRAX Virax Biolabs Group Limited — -0.1 -207.4 -812.1 -40439.1 -87.7 4 BEARISH 255.2
XENO Xeno Transplants Corporation — -0.0 -286.5 78.1 — — 1 BEARISH 0.0
EFTR eFFECTOR Therapeutics, Inc. — -0.0 1737.6 607.9 — -91.9 4 BEARISH 0.0
RMTG Regenerative Medical Technology Group Inc. — -0.1 9.6 -3.3 -72.2 — 3 BEARISH —
CHMMF Chimeric Therapeutics Limited — -0.0 1115.1 183.2 — 98.4 3 BEARISH 0.0
IDRSF Idorsia Ltd $1.4B -3.4 27.1 -344.5 -203.1 -8.1 1 BEARISH 17.0
CGEM Cullinan Therapeutics, Inc. $950M -4.6 -50.3 1635.6 — — 1 BEARISH 158.5
JBIO Jade Biosciences, Inc. $860M -5.1 -47.8 629.9 — — 3 BEARISH 55.0
MNPR Monopar Therapeutics Inc. $520M -33.3 -19.5 523.8 — — 2 BEARISH -8.0
ASMB Assembly Biosciences, Inc. $450M 41.0 -0.0 56.2 -28.8 125.1 4 BEARISH -8.4
ABEO Abeona Therapeutics Inc. $290M -4.4 -43.1 -5983.3 -177.4 6280.0 2 BEARISH -4.7
PRQR ProQR Therapeutics N.V. $170M -3.7 -57.9 139.7 -99.6 12.7 2 BEARISH -24.1
IMUX Immunic, Inc. $110M -1.7 -138.2 345.6 — — 5 BEARISH -17.1
BMEA Biomea Fusion, Inc. $90M -2.6 -164.1 210.3 — — 2 BEARISH -39.2
PMN ProMIS Neurosciences, Inc. $80M -0.6 -172.3 844.3 — — 2 BEARISH -17.5
AVEFF Avecho Biotechnology Limited $20M -13.3 -238.0 200.0 -3227.5 83.1 5 BEARISH 0.0
CMMB Chemomab Therapeutics Ltd. $10M -1.4 -82.7 -314.7 — — 1 BEARISH -45.8
SILO Silo Pharma, Inc. — -0.3 -91.2 645.1 — -25.0 3 BEARISH 113.0
OZYMF Strategic Partners A/S — 21.7 0.9 -117.6 1019.0 — 5 BEARISH 0.0
ANTH Anthera Pharmaceuticals, Inc. — -0.0 -251.4 1107.5 — — 1 BEARISH 0.0
GNLKQ GeneLink, Inc. — -0.0 73.0 82.1 -183.0 -33.6 3 BEARISH 0.0
GLABF Gemina Laboratories Ltd. — -3.0 42.7 32.4 -7838.5 — 5 BEARISH -85.1
MAJI Nextel Medical Corp. — -0.8 -0.6 7.4 — — 1 BEARISH —
SNDX Syndax Pharmaceuticals, Inc. $1.6B -7.0 -255.9 -270.9 -67.8 222.3 4 BEARISH 12.2
HBMHF HBM Holdings Limited $1.3B 17.0 58.2 96.1 53.0 133.3 6 BEARISH -8.8
ARDX Ardelyx, Inc. $830M -14.8 -38.6 -22.7 -13.8 16.8 4 BEARISH -37.7
LXEO Lexeo Therapeutics, Inc. Common Stock $280M -3.1 -46.8 -249.1 — — 3 BEARISH -46.8
BOVNF BioInvent International AB (publ) $220M -3.0 -88.2 20101.5 -964.0 -87.2 1 BEARISH 0.0
EDSA Edesa Biotech, Inc. $40M -2.3 -122.9 759.6 — — 1 BEARISH 50.2
CNTX Context Therapeutics Inc. $30M -0.6 -76.1 841.7 — — 2 BEARISH -68.1
CLCS Cell Source, Inc. $30M -4.0 27.7 34.5 — — 4 BEARISH 11.9
NAVBQ Navidea Biopharmaceuticals, Inc. — — — — — — — BEARISH —
RNAZ TransCode Therapeutics, Inc. — -0.0 -59.2 -21.0 — — 1 BEARISH -85.2
CLDI Calidi Biotherapeutics, Inc. — -0.0 -713.6 -1404.6 — — 4 BEARISH -95.9
ELAB PMGC Holdings Inc. — -0.0 -73.0 -66.6 -225.1 408.6 3 BEARISH -99.9
RADX Radiopharm Theranostics Limited — — — — — — — BEARISH -74.7
AGTX Agentix Corp. — -1.9 14.5 10.8 — — 3 BEARISH -55.6
PPBT Purple Biotech Ltd. — -0.0 -111.3 -99.1 — — 2 BEARISH 157.7
MYNDF MYND Life Sciences Inc. — -2.2 9.5 34.0 — — 5 BEARISH -41.3
ZLDAF Zelira Therapeutics Limited — -1.6 -294.0 349.6 -185107971.7 -94.8 1 BEARISH -1.4
ADXN Addex Therapeutics Ltd — -0.5 -150.5 -168.4 -17543.0 -48.1 2 BEARISH -67.3
ENDV Endonovo Therapeutics, Inc. — -0.1 9.2 4.5 — -100.0 3 BEARISH -50.0
PREDQ Predictive Discovery Limited — — — — — — — BEARISH —
ARUXF Acrux Limited — -7.1 -276.2 -405.6 -26.5 -56.9 3 BEARISH -93.4
ACUT Accustem Sciences Inc. — -1.3 49.7 34.0 -256.7 2610.7 4 BEARISH -91.0
SEPSF Asep Medical Holdings Inc — -0.4 -36.4 -75.5 -844.8 208.8 5 BEARISH -97.2
AGIO Agios Pharmaceuticals, Inc. $1.9B -4.5 -34.3 -82.5 -225.1 140.6 4 BEARISH -20.6
ZYME Zymeworks Inc. $1.9B -12.5 -72.3 -156.9 -980.8 -69.8 2 BEARISH 48.5
NUVB Nuvation Bio Inc. $1.8B -11.8 -47.8 70.2 -198.3 1083.6 4 BEARISH 38.6
CMPS COMPASS Pathways plc $1.6B -2.1 -319.1 48.8 — — 2 BEARISH 106.2
IMCR Immunocore Holdings plc $1.5B -164.8 -2.3 -472.0 -0.7 13.4 4 BEARISH -17.3
TSHA Taysha Gene Therapies, Inc. $1.5B -11.0 -47.1 961.0 — -32.3 3 BEARISH 45.6
INBX Inhibrx Biosciences Inc. $1.4B -10.9 -1773.6 55.8 — -100.0 4 BEARISH 185.4
NBTX Nanobiotix S.A. $1.3B -20.8 380.7 158.8 -941.2 -73.7 3 BEARISH 37.4
KURA Kura Oncology, Inc. $950M -3.2 -167.7 56.3 -327.3 -7.3 1 BEARISH 15.8
CADL Candel Therapeutics, Inc. $750M -7.2 -81.8 219.4 — — 2 BEARISH 83.8
ZVRA Zevra Therapeutics, Inc. $590M 10.4 34.8 -1356.4 22.1 119.4 6 BEARISH 5.9
PRME Prime Medicine, Inc. $540M -2.7 -373.3 -271.3 -3649.0 -17.9 3 BEARISH -46.7
AUTL Autolus Therapeutics plc $470M -1.7 -132.9 451.5 -85.6 292.0 3 BEARISH 6.6
OVID Ovid Therapeutics Inc. $440M -5.0 -26.0 -43.7 -2047.6 -76.2 3 BEARISH 73.7
NGNE Neurogene Inc. $410M -4.7 -45.3 -111469.0 — — 2 BEARISH 42.7
CCCC C4 Therapeutics, Inc. $330M -3.0 -48.1 -175.0 -355.9 2.3 4 BEARISH 37.2
CYDY CytoDyn Inc. $270M -5.8 41.5 21.3 — 100.0 3 BEARISH -23.0
IFRX InflaRx N.V. $250M -3.1 -38.5 251.5 — -106.2 4 BEARISH 26.5
CGEN Compugen Ltd. $220M 6.2 49.6 -90.2 -269.3 886.7 5 BEARISH 44.4
CUE Cue Biopharma, Inc. $190M -0.9 -1603.5 1241.9 -1943.2 354.4 3 BEARISH 17.8
IPHA Innate Pharma S.A. $150M -2.6 1600.0 254.7 -630.0 -91.4 2 BEARISH -21.2
ABOS Acumen Pharmaceuticals, Inc. $150M -1.2 -120.5 389.8 — — 2 BEARISH 16.6
PYXS Pyxis Oncology, Inc. $140M -1.5 -179.1 1953.9 — 291.4 2 BEARISH -2.3
MXCT MaxCyte, Inc. $110M -3.2 -20.4 -38.9 -122.0 -13.2 2 BEARISH -33.1
VRCA Verrica Pharmaceuticals Inc. $80M -2.5 473.3 437.4 -224.4 106.2 5 BEARISH -1.4
BETRF BetterLife Pharma Inc. $30M -12.0 14.6 14.7 — — 4 BEARISH 252.4
LPCN Lipocine Inc. $20M -1.1 -60.9 662.3 -1379.6 -62.7 2 BEARISH -31.0
KZIA Kazia Therapeutics Ltd ADR $20M -1.3 -196.1 162.7 — 250944.3 5 BEARISH 35.3
AKTX Akari Therapeutics, Plc $10M -0.0 -139.9 -175.8 — — 3 BEARISH -77.8
IMNN Imunon, Inc. $10M -0.3 -429.7 -226.7 — — 2 BEARISH -75.6
EVFM Evofem Biosciences, Inc. — -0.1 20.1 26.0 -419.1 4.5 2 BEARISH -44.8
IMNM Immunome, Inc. $2.0B -8.2 -64.0 -2208.4 — -100.0 4 BEARISH 84.3
TRVI Trevi Therapeutics, Inc. $2.0B -41.2 -19.7 -1451.7 — — 3 BEARISH 48.0
QURE uniQure N.V. $1.6B -5.8 -157.6 37.9 -1387.8 30.2 4 BEARISH -57.3
RAPP Rapport Therapeutics, Inc. Common Stock $1.5B -10.6 -40.0 3981.5 — — 4 BEARISH 12.2
OCUL Ocular Therapeutix, Inc. $1.5B -4.9 -73.0 -31671.3 -584.5 -8.1 3 BEARISH -37.0
ANAB AnaptysBio, Inc. $1.4B 7.2 -1146.3 466.0 668.9 92.9 5 BEARISH 127.7
NKTR Nektar Therapeutics $1.2B -6.5 -35.8 -29.2 -401.0 -27.2 3 BEARISH -25.9
BCAX Bicara Therapeutics Inc. Common Stock $1.2B -5.7 -41.0 583.9 — — 2 BEARISH 6.1
LBRX LB Pharmaceuticals Inc Common Stock $1.1B -12.5 -25.8 -768.9 — — 2 BEARISH 134.7
MGTX MeiraGTx Holdings plc $1.0B 14.2 72.3 96.7 50.0 948.3 7 BEARISH 30.5
AKTS Aktis Oncology, Inc. $990M -17.6 -29.9 276.4 -713.5 -36.1 5 BEARISH 18875.4
ANRO Alto Neuroscience, Inc. $870M -10.0 -49.2 -201.4 — — 3 BEARISH 509.6
AVTX Avalo Therapeutics, Inc. $790M -3.2 -36.3 -148.4 — -86.6 4 BEARISH 15.7
SLDB Solid Biosciences Inc. $670M -3.6 -65.5 -1012.6 — — 3 BEARISH 16.7
CLYM Climb Bio, Inc. $630M -13.2 -27.1 -88.6 — — 2 BEARISH 455.3
AURA Aura Biosciences, Inc. $630M -3.4 -53.5 -1360.0 — — 4 BEARISH -1.0
IMMX Immix Biopharma, Inc. $530M -11.0 -34.2 1509.2 — — 4 BEARISH 365.4
TECX Tectonic Therapeutic, Inc. $430M -4.9 -33.8 -6371.3 — — 1 BEARISH 43.9
FENC Fennec Pharmaceuticals Inc. $350M -78.5 -18.6 -76.2 11.0 77.8 6 BEARISH 6.4
ARTV Artiva Biotherapeutics, Inc. $330M -2.1 -36.6 -954.6 — — 3 BEARISH 133.9
SPHDF Santhera Pharmaceuticals Holding AG $270M -6.6 -464.2 715.5 -44.5 26.5 3 BEARISH 37.4
IKT Inhibikase Therapeutics, Inc. $260M -4.2 -52.0 920.5 — — 3 BEARISH 24.2
QTTB Q32 Bio Inc. $240M 2.9 72.1 435.2 — — 5 BEARISH 295.7
PRLD Prelude Therapeutics Incorporated $210M -4.6 -57.7 14236.3 -244.1 220.3 5 BEARISH 143.1
ZNTL Zentalis Pharmaceuticals, Inc. $180M -1.0 -83.7 -2245.4 — -100.0 2 BEARISH 63.6
ALXO ALX Oncology Holdings Inc. $160M -1.1 -80.6 -851.1 — — 4 BEARISH -32.6
CRBP Corbus Pharmaceuticals Holdings, Inc. $110M -0.9 -95.6 738.2 — — 1 BEARISH -53.0
CRDF Cardiff Oncology, Inc. $90M -1.9 -94.1 443.4 -8876.9 -7.0 3 BEARISH -46.1
ACET Adicet Bio, Inc. $60M -0.6 -78.1 -553.5 — — 4 BEARISH -50.6
SER Serina Therapeutics, Inc. $30M -1.0 -206.3 1868.6 — -100.0 3 BEARISH -62.7
XTLB XTL Biopharmaceuticals Ltd. — -1.0 -26.8 -38.7 -88.2 — 3 BEARISH 87.8
HXBM Helix BioMedix, Inc. — — — — — — — BEARISH -6.0
CDT CDT Equity Inc. — -0.0 13.1 5.4 9.1 — 7 BEARISH -82.2
BRVE Braveheart Bio, Inc. $1.5B — — — — — — BEARISH —
APMD Apnimed, Inc. $860M — — — — — — BEARISH —
GENSF Genus plc $1.9B 5.0 45.8 14.4 80.4 28.9 7 BEARISH -17.7
COAG Hemab Therapeutics Holdings, Inc. Common Stock $1.4B — — — — — — BEARISH —
KLRA Kailera Therapeutics, Inc. $1.4B — — — — — — BEARISH —
KARD Kardigan, Inc. $1.3B — — — — — — BEARISH —
AVLN Avalyn Pharma Inc. Common Stock $1.2B — — — — — — BEARISH —
SPTX Seaport Therapeutics, Inc. Common Stock $990M — — — — — — BEARISH —
MLTX MoonLake Immunotherapeutics $960M -3.0 -67.4 2902.7 — — 1 BEARISH 61.6
WVE Wave Life Sciences Ltd. $740M -3.5 -68.3 -2645.3 -3052.6 -30.4 5 BEARISH -46.2
FTH Faeth Therapeutics, Inc. $730M — — — — — — BEARISH —
OCS Oculis Holding AG $500M -5.2 -44.0 -31.0 — -6.9 3 BEARISH -49.8
DRUG Bright Minds Biosciences Inc. $500M -24.3 -13.7 -105758.3 — — 3 BEARISH -12.5
PRTA Prothena Corporation plc $440M -10.1 -14.4 -871.5 -1839.9 427.3 5 BEARISH -15.7
MPLT MapLight Therapeutics, Inc. $420M -1.9 -57.5 -366.6 — — 2 BEARISH —
ZURA Zura Bio Limited $390M -3.6 -54.3 910.3 — — 2 BEARISH 1.7
CABA Cabaletta Bio, Inc. $330M -1.3 -93.2 -1308.0 — — 3 BEARISH -13.4
BBOT BridgeBio Oncology Therapeutics Inc. $310M -0.0 -56.4 -157.3 — — 1 BEARISH -67.7
FULC Fulcrum Therapeutics, Inc. $280M -3.0 -32.4 2389.1 — — 4 BEARISH -60.5
SABS SAB Biotherapeutics, Inc. $270M 0.8 -11.3 -48.4 — -100.0 3 BEARISH 50.5
NWBO Northwest Biotherapeutics, Inc. $250M -6.0 55.8 -188.7 -1142.6 98.6 3 BEARISH -39.7
PALI Palisade Bio, Inc. $250M -2.7 -51.4 815.6 -2114.8 — 5 BEARISH 9.9
HLOSF Healios K.K. $240M 57.9 3.7 -129.2 17028.6 -47.1 4 BEARISH -56.6
AKBA Akebia Therapeutics, Inc. $230M -8.0 -109.4 15.6 -18.1 7.5 6 BEARISH -67.7
NAGE Niagen Bioscience Inc $220M 14.4 21.8 44.7 3.2 11.0 6 BEARISH -64.6
YARW Yarrow Bioscience Inc $210M — — — — — — BEARISH —
VRXA Veraxa Biotech Holding AG $160M — — — — — — BEARISH —
NBP NovaBridge Biosciences $160M -2.4 -45.7 -617.8 — — 1 BEARISH -64.8
CMPX Compass Therapeutics, Inc. $150M -2.1 -56.7 1526.3 — — 4 BEARISH -74.5
IMRX Immuneering Corporation $150M -3.9 -52.1 -112.8 — — 4 BEARISH -36.0
TNXP Tonix Pharmaceuticals Holding Corp. $140M -0.7 -81.8 -276.2 -299.4 196.0 3 BEARISH -62.8
CLLS Cellectis S.A. $140M -2.2 -94.6 118.6 -417.3 0.5 2 BEARISH -56.5
MIST Milestone Pharmaceuticals Inc. $100M -1.2 -35522.6 587.8 -5118.8 — 5 BEARISH -52.1
ORPOF OSE Immunotherapeutics S.A. $100M — — — — — — BEARISH —
HUMA Humacyte, Inc. $90M -1.0 -547.9 -500.7 -9064.5 -73.6 3 BEARISH -70.4
INO Inovio Pharmaceuticals, Inc. $80M -1.0 -409.9 257.7 — -100.0 1 BEARISH -51.0
JWCTF JW (Cayman) Therapeutics Co. Ltd $80M -2.9 -98.4 -35.5 -45.3 36.2 4 BEARISH -58.9
GANX Gain Therapeutics, Inc. $70M -3.4 -268.3 1288.8 — — 4 BEARISH -6.0
RECEF Recce Pharmaceuticals Ltd $70M -6.3 277.4 402.1 — 11.3 2 BEARISH -63.3
MAIA MAIA Biotechnology, Inc. $70M -1.9 -218.7 330.4 — — 3 BEARISH -28.3
KLRS Kalaris Therapeutics Inc $60M -1.3 -79.9 109.5 — — 0 BEARISH -55.5
DWTX Dogwood Therapeutics, Inc. $50M -0.2 -47.8 -39.7 — — 2 BEARISH -79.3
IMA ImageneBio Inc $50M -0.9 -40.7 -594.7 — — 3 BEARISH -46.0
BSEM BioStem Technologies, Inc. $50M -1.6 -74.7 -84.3 -113.6 -119.6 2 BEARISH -45.3
GRCE Grace Therapeutics, Inc. $30M -1.6 -13.8 -21.9 — — 1 BEARISH -32.6
ESLA Estrella Immunopharma, Inc. $20M -1.9 148.1 102.1 — — 3 BEARISH -65.1
NXTC NextCure, Inc. $20M -0.5 -195.2 949.7 — — 2 BEARISH -10.5
DTCFF Defence Therapeutics Inc. $20M -3.5 -237.8 -86.8 — — 4 BEARISH -45.0
MRKR Marker Therapeutics, Inc. $20M -2.2 -76.9 -1014.3 — -77.1 2 BEARISH 15.6
LGVN Longeveron Inc. $10M -0.3 -203.6 -2062.6 -2116.0 -42.7 4 BEARISH -65.2
CKDXF Ceryvyn Therapeutics Limited $10M 0.2 -234.2 64023.3 — -92.0 4 BEARISH -97.7
CALC CalciMedica, Inc. $10M -0.2 -365.7 118.3 — — 4 BEARISH -89.5
INTS Intensity Therapeutics, Inc. $10M -0.7 -195.9 4123.4 — — 5 BEARISH -46.6
XCUR Exicure, Inc. $10M -0.9 -168.4 779.8 — — 2 BEARISH -72.0
OPTBF OptiBiotix Health PLC $10M -1.4 -102.1 -102.1 -231.5 -12.9 4 BEARISH 109900.0
GSGTF GenSight Biologics S.A. $10M -1.1 104.0 107.2 848.8 -139.6 2 BEARISH -57.9
IUGNF Imugene Limited $10M -0.1 -273.9 -901.2 — -73.7 1 BEARISH -87.2
PLUR Pluri Inc. $10M -0.4 163.6 -483.9 -1755.2 -24.0 2 BEARISH -76.8
ZEOX Zeo ScientifiX, Inc. $10M -2.2 -140.0 105.8 -5.6 — 2 BEARISH —
BLRX BioLineRx Ltd. $10M -1.4 -63.5 -113.0 -1029.3 -94.3 3 BEARISH -38.8
QNRX Quoin Pharmaceuticals, Ltd. $10M -0.3 -578.6 221.3 — — 1 BEARISH -38.2
LNAI Lunai Bioworks Inc. $10M -0.0 -21.6 30.2 — — 2 BEARISH -87.0
ENLV Enlivex Therapeutics Ltd. $10M 0.0 209.7 -0.4 — — 5 BEARISH -97.4
PXXLF Poxel S.A. $10M -0.4 222.8 275.8 -624.6 -73.2 2 BEARISH -12.0
FNAM Evolutionary Genomics, Inc. — -0.0 62.2 -99.6 — — 2 BEARISH 0.0
KAPA Kairos Pharma, Ltd. — -0.8 -114.0 -301.0 — — 3 BEARISH -80.3
SUVZ Suvanza Pharma, LLC — — — — — — — BEARISH 0.0
VSBC VitaSpring Biomedical Co. Ltd. — -4.8 35.7 8.9 — -100.0 3 BEARISH -98.9
PXMD PaxMedica, Inc. Common Stock — -0.0 -7716.2 572.1 — — 2 BEARISH 400.0
ENZC Enzolytics Inc. — -9.3 105.9 1.4 — — 7 BEARISH 100.0
LEXX Lexaria Bioscience Corp. — -0.5 -150.3 -504.2 — -68.5 4 BEARISH -80.9
CVKD Cadrenal Therapeutics, Inc. Common Stock — -0.2 -275.2 -540.4 — — 3 BEARISH -93.1
VRXAW Veraxa Biotech AG — — — — — — — BEARISH —
PCSA Processa Pharmaceuticals, Inc. — -0.3 -464.2 1977.5 — — 2 BEARISH -67.5
BNIGF Beroni Group Limited — -0.1 -1153.4 -274.8 -15945.7 -40.4 4 BEARISH 0.0
WSNAF Wesana Health Holdings Inc. — -0.1 1113.6 90.8 — — 3 BEARISH -87.1
MBAI MBody AI Ltd. — — — — — — — BEARISH —
NBRVF Nabriva Therapeutics plc — — — — — — — BEARISH -0.0
IBOGF Universal Ibogaine Inc. — -0.5 -94.8 5.5 -9.4 208.2 4 BEARISH -98.8
HMGN Hemagen Diagnostics, Inc. — -0.0 29.1 -24.6 -18.6 -21.4 2 BEARISH 100.0
RASP Actavia Life Sciences, Inc. — -0.1 20.1 14.5 — — 2 BEARISH -87.5
TCRT Alaunos Therapeutics, Inc. — -0.4 -185.9 -607.2 — -50.0 1 BEARISH -66.9
BICTF Biocure Technology Inc. — -0.1 -889.9 60.0 — — 1 BEARISH 0.0
BBLG Bone Biologics Corporation — -0.3 -55.0 2257.6 — — 2 BEARISH -83.0
RGRX RegeneRx Biopharmaceuticals, Inc. — -0.0 53.5 45.8 -2006.3 -0.0 3 BEARISH 450.0
TNGNQ Tengion, Inc. — — — — — — — BEARISH 0.0
FBLG FibroBiologics, Inc. Common Stock — -0.2 -660.1 -511.6 — — 4 BEARISH -88.2
ADTX Aditxt, Inc. — -0.0 622.6 49.4 -131159.8 -74.1 1 BEARISH -100.0
ITMC Itoco Inc. — -0.0 303.4 96.7 — — 2 BEARISH 0.0
BPTSY Biophytis S.A. — -0.0 376.0 1163.5 — — 2 BEARISH -87.5
VPRO Viropro Inc. — -0.0 -19.7 -4.8 -269.7 155.0 2 BEARISH 0.0
DRMA Dermata Therapeutics, Inc. — -0.3 -183.9 734.5 — — 2 BEARISH -78.4
ONCSQ OncoSec Medical Incorporated — -0.0 -410.2 452.1 — — 2 BEARISH -90.0
VIVS VivoSim Labs, Inc. — -0.0 1259.6 159.9 -14410.0 — 2 BEARISH -93.9
SRPT Sarepta Therapeutics, Inc. $1.9B -12.2 -9.5 -6.3 -1.2 -20.4 4 BEARISH -9.4
MESO Mesoblast Limited $1.8B -32.0 -9.9 -6.3 -25.2 599.2 5 BEARISH -13.5
GENB Generate Biomedicines, Inc. $1.8B -12.9 -28.2 -175.0 -1065.2 — 1 BEARISH —
GPCR Structure Therapeutics Inc. $1.6B -9.1 -20.2 -1134.3 — — 3 BEARISH 6.3
INVA Innoviva, Inc. $1.5B 4.2 36.7 15.0 -69.8 19.8 7 BEARISH 12.8
ASPHF Ascentage Pharma Group International $1.4B -6.4 -316.9 -211.0 -270.2 -29.1 1 BEARISH -58.3
DMRA Damora Therapeutics, Inc. $1.3B — — — — — — BEARISH —
TRAX First Tracks Biotherapeutics Inc $1.2B — — — — — — BEARISH —
ASCLF Ascletis Pharma Inc. $1.1B -11.7 -38.0 -12387.1 — -95.5 2 BEARISH -14.8
CRVS Corvus Pharmaceuticals, Inc. $920M -17.0 -35.4 -415.6 — — 4 BEARISH 50.1
GLUE Monte Rosa Therapeutics, Inc. $890M -4.8 -42.7 149.9 -483.9 -83.9 3 BEARISH 40.0
ALMS Alumis Inc. $850M -1.8 -93.6 2645.2 -8557.2 -63.1 2 BEARISH 68.7
SANA Sana Biotechnology, Inc. $800M -3.8 -152.9 -242.3 — — 3 BEARISH -21.9
GERN Geron Corporation $770M -12.0 -29.2 -74.1 -29.0 24.4 2 BEARISH -14.9
IVEVF Inventiva S.A. $760M -5.9 5541.6 502.1 -347346.6 -57.3 4 BEARISH 41.2
ATTO Attovia Therapeutics, Inc. $740M -18.5 -294.4 -1137.2 -4597.1 -50.5 4 BEARISH 308.8
OLMA Olema Pharmaceuticals, Inc. $720M -3.9 -52.7 585.3 — — 2 BEARISH -25.4
BLSM BlossomHill Therapeutics, Inc. $570M — — — — — — BEARISH —
CRMD CorMedix Inc. $560M 3.0 54.9 57.2 25.5 280.5 5 BEARISH -34.9
CTMX CytomX Therapeutics, Inc. $560M -5.7 -37.8 305.9 -1457.4 -87.0 2 BEARISH -23.6
PHAT Phathom Pharmaceuticals, Inc. $560M -5.4 26.4 8.9 -23.7 110.2 4 BEARISH -43.7
ALT Altimmune, Inc. $530M -3.5 -28.9 -43.1 — 55.0 4 BEARISH -20.4
ALLO Allogene Therapeutics, Inc. $520M -2.2 -42.4 -81.9 -919.8 — 5 BEARISH 21.0
ARVN Arvinas, Inc. $480M 39.0 1.6 -519.3 67.8 -15.0 4 BEARISH -18.8
AGMB AgomAb Therapeutics N.V. American Depositary Shares $420M — — — — — — BEARISH —
SPRY ARS Pharmaceuticals, Inc. $400M -1.9 -210.3 -424.3 -185.2 4.1 2 BEARISH -59.7
PTCHF PureTech Health plc $380M 8.2 14.7 -97.5 1890.6 -3.3 5 BEARISH -0.7
KYTX Kyverna Therapeutics, Inc. $380M -2.1 -87.2 14267.8 — — 2 BEARISH 4.2
RLMD Relmada Therapeutics, Inc. $380M -3.9 -55.7 460.5 — — 3 BEARISH 66.7
RGNX REGENXBIO Inc. $380M -2.0 -137.6 -368.4 21.0 12.0 2 BEARISH -23.9
BNTC Benitec Biopharma Inc. $310M -9.2 -33.2 1840.8 — — 3 BEARISH -29.6
LRMR Larimar Therapeutics, Inc. $310M -1.5 -139.6 590.9 — — 2 BEARISH -28.7
VNDA Vanda Pharmaceuticals Inc. $280M -1.0 -77.8 -201.0 -123.7 6.0 3 BEARISH -9.2
RCKT Rocket Pharmaceuticals, Inc. $280M -16.0 -4.8 -137.8 — — 3 BEARISH -19.0
IPSC Century Therapeutics, Inc. $280M -1.5 -49.7 -60.0 — -100.0 2 BEARISH 206.1
EYPT EyePoint Pharmaceuticals, Inc. $270M -0.9 -148.7 -3014.8 -18633.1 -94.6 2 BEARISH -74.8
XFOR X4 Pharmaceuticals, Inc. $270M -2.4 -113.1 -281.1 -183.5 -51.6 4 BEARISH -21.8
SCTX Scribe Therapeutics Inc. $270M — — — — — — BEARISH —
ORYZF Oryzon Genomics S.A. $250M -87.6 -3.0 -7.2 -1.6 12.6 4 BEARISH -8.3
DBVT DBV Technologies S.A. $250M -2.7 -142.6 -2201.5 — -100.0 2 BEARISH 4.8
VOGX Vogenx Inc. $250M — — — — — — BEARISH —
BIOA BioAge Labs Inc. $250M -2.8 -28.2 -142.3 -1064.7 168.1 4 BEARISH 11.7
EVMN Evommune, Inc. $250M -2.4 -29.6 -82.4 — — 2 BEARISH —
LYEL Lyell Immunopharma, Inc. $230M -0.6 -93.3 -227.7 -1118875.0 -55.0 3 BEARISH -44.0
BCYC Bicycle Therapeutics plc $230M -1.2 -32.3 -1197.0 -8002.1 217.4 4 BEARISH -59.4
LCTX Lineage Cell Therapeutics, Inc. $230M -6.6 -59.0 -171.3 138.6 19.9 5 BEARISH -45.0
SION Sionna Therapeutics, Inc. $220M -2.3 -32.3 -137.7 — — 0 BEARISH -82.8
CHRS Coherus Oncology, Inc. $180M -1.1 -145.4 1854.0 -144.2 -64.3 2 BEARISH -28.4
AVXL Anavex Life Sciences Corp. $170M -7.0 -23.6 411.7 — — 2 BEARISH -79.8
PEPG PepGen Inc. $160M -1.5 -75.5 -327.5 — — 4 BEARISH -51.6
VYGR Voyager Therapeutics, Inc. $150M -1.4 -54.1 -131.1 -773.2 -19.1 2 BEARISH -47.6
TARA Protara Therapeutics, Inc. $150M -2.0 -45.8 -41.3 — — 2 BEARISH -38.8
NGEN NervGen Pharma Corp. Common stock $150M — — — — — — BEARISH —
NERV Minerva Neurosciences, Inc. $150M -0.1 337.5 10.0 — — 1 BEARISH 56.2
SPRB Spruce Biosciences, Inc. $130M -1.1 -106.0 772.2 — -100.0 4 BEARISH 413.6
RNA Atrium Therapeutics, Inc. $130M -2.0 -36.9 455.9 -672.0 235.3 5 BEARISH -82.0
CRBU Caribou Biosciences, Inc. $120M -1.1 -78.3 -695.0 -1619.9 10.0 3 BEARISH -46.0
TNYA Tenaya Therapeutics, Inc. $120M -1.1 -121.9 1769.3 -3909.3 — 3 BEARISH -66.4
VXRT Vaxart, Inc. $110M 2.9 67.0 149.6 -49.6 201.1 6 BEARISH 15.0
UNCY Unicycive Therapeutics, Inc. $110M -2.5 -101.1 349.9 — — 4 BEARISH -5.4
LENZ LENZ Therapeutics, Inc. $110M -0.9 -59.2 17313.3 -581.8 329.5 3 BEARISH -92.7
OKUR OnKure Therapeutics, Inc. $100M -0.7 -46.9 1464.5 — — 4 BEARISH -4.1
NMRA Neumora Therapeutics, Inc. Common Stock $90M -0.4 -187.1 231.9 — — 2 BEARISH -71.3
CNXU Conexeu Sciences Inc. $80M — — — — — — BEARISH —
CGTX Cognition Therapeutics, Inc. $80M -4.8 -83.8 6061.8 — — 3 BEARISH -38.7
NTHI Neonc Technologies Holdings, Inc. $80M — — — — — — BEARISH -69.7
ALDX Aldeyra The $70M -3.0 -49.5 269.3 — — 4 BEARISH -77.7
PTHS Pelthos Therapeutics Inc. $70M -0.5 4767.3 -97.0 -150.1 — 2 BEARISH -23.7
CING Cingulate Inc. $60M -1.0 -198.7 -1452.8 — — 4 BEARISH 13.6
PLRX Pliant Therapeutics, Inc. $60M -0.7 -50.3 -438.3 — — 3 BEARISH -29.0
GUTS Fractyl Health, Inc. $60M -0.4 1063.0 -568.7 — -100.0 4 BEARISH -72.3
ONCY Oncolytics Biotech Inc. $60M -2.6 90135.4 285.1 — — 1 BEARISH -56.1
HBPCF Helix BioPharma Corp. $60M -22.3 -50.8 -21.5 — — 3 BEARISH 28.3
PRRUF Immutep Ltd $40M -0.6 -96.5 2212.5 -328.8 153.6 3 BEARISH -84.2
MGX Metagenomi, Inc. Common Stock $40M -0.4 -60.6 -268.2 10693.4 -59.8 1 BEARISH -57.3
KYNB Kyntra Bio, Inc. $30M 0.1 -115.2 29.6 -812.3 — 2 BEARISH —
MCRB Seres Therapeutics, Inc. $30M -1.2 -66.6 -87.8 622.4 — 3 BEARISH -85.7
ATYR aTyr Pharma, Inc. $30M -0.5 -98.4 -1890.1 — — 2 BEARISH -58.4
IMMP Immutep Limited $30M -0.6 -112.5 2661.4 -328.8 195.3 4 BEARISH -88.0
BCDA BioCardia, Inc. $20M -1.4 -1803.2 519.4 — — 3 BEARISH -21.8
ACXP Acurx Pharmaceuticals, Inc. $10M -0.4 -128.1 241.9 — — 3 BEARISH -72.4
RDTCF Rapid Dose Therapeutics Corp. $10M -4.2 54.7 78.9 -106.0 33.0 3 BEARISH -49.1
HMTXF Hemostemix Inc $10M -2.4 69.9 190.1 — — 1 BEARISH -38.1
LTRN Lantern Pharma Inc. $10M -0.5 -400.9 115.9 — — 2 BEARISH -78.5
OTLC Oncotelic Therapeutics, Inc. $10M 0.0 0.0 -0.0 155.3 — 5 BEARISH -69.5
PASG Passage Bio, Inc. $10M -0.4 -169.1 159.0 — — 3 BEARISH -49.3
PRVCF PreveCeutical Medical Inc. $10M -16.7 9.9 96.4 — — 3 BEARISH -56.2
MSLE Satellos Bioscience Inc. $10M — — — — — — BEARISH —
CLRB Cellectar Biosciences, Inc. $10M -0.4 -119.6 717.6 — — 3 BEARISH -69.2
PHIO Phio Pharmaceuticals Corp. $10M -0.7 -113.7 2701.6 — — 2 BEARISH -59.3
TVRD Tvardi Therapeutics, Inc. $10M -0.4 -126.2 296.9 — — 1 BEARISH -97.0
JSPR Jasper Therapeutics, Inc. $10M -0.4 -255.0 773.9 — — 2 BEARISH -76.5
LABT Lakewood-Amedex Biotherapeutics, Inc. — — — — — — — BEARISH —
PBIGF Paradigm Biopharmaceuticals Limited — -1.6 -550.4 1492.1 -60158.9 17.4 3 BEARISH -99.2
MBIO Mustang Bio, Inc. — -1.0 -58.1 36.6 — — 2 BEARISH -70.0
GOVX GeoVax Labs, Inc. — -0.0 -891.6 1530.7 — -100.0 3 BEARISH -97.6
BRTX BioRestorative Therapies, Inc. — -0.1 -241.1 2112.9 -9298.3 -8.5 3 BEARISH -92.3
BLEG Branded Legacy, Inc. — -0.0 2011.7 147.0 — -29.4 2 BEARISH -98.6
AGNPF Grey Matters Health Inc. — — -140.9 -64.7 — — 3 BEARISH -50.0
YECO EV Biologics, Inc. — -0.0 4.7 15.0 18.6 347.3 6 BEARISH -99.9
ERNA Ernexa Therapeutics Inc. — -0.2 -320.7 626.9 — -100.0 5 BEARISH -89.6
AXIM AXIM Biotechnologies, Inc. — -1.6 3.0 24.9 -90.9 2142.6 5 BEARISH -38.2
PKTX ProtoKinetix, Incorporated — -0.7 -117.2 -115.0 — — 2 BEARISH -96.4
ZVSA ZyVersa Therapeutics, Inc. — -0.0 817.1 242.0 — -100.0 1 BEARISH -44.1
SCPS Scopus BioPharma Inc. — -0.0 132.3 53.6 — — 2 BEARISH 33.3
REVB Revelation Biosciences, Inc. — -0.1 -154.8 1317.2 — — 3 BEARISH -47.9
CYYNF Cynata Therapeutics Limited — -0.3 -542.5 1354.9 — -40.0 2 BEARISH -98.8
XAGE Longevity Health Holdings Inc. — -0.0 109.8 56.6 -475.6 60.3 3 BEARISH -79.8
CRIS Curis, Inc. — -0.1 455.3 -23281.0 — -62.2 3 BEARISH -97.6
MBRX Moleculin Biotech, Inc. — -0.0 -1371.6 -494.1 — — 2 BEARISH -96.4
AZTR Azitra, Inc. — -0.1 -256.7 -959.6 — — 4 BEARISH -81.7
GBLX GB Sciences, Inc. — -0.0 19.5 17.2 -103.2 — 3 BEARISH -50.0
CLAZF Claritas Pharmaceuticals, Inc. — 0.0 -170.1 15.9 — — 3 BEARISH -99.0
BXRXQ Baudax Bio, Inc. — — — — — — — BEARISH -90.0

Profile Radar

Valuation vs Profitability

Performance Comparison

Industry Market Share

BCLI vs Benchmarks

ROIC
BCLI
76.7
Industry
11.2
Revenue Growth
BCLI
-100.0
Sector
0.8
P/E Ratio
BCLI
-1.0
Sector
17.0
ROE
BCLI
119.2
Sector
-70.3
Piotroski F
BCLI
1.0
Sector
3.0

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms